Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  HIV Infection

  Free Subscription


Articles published in J Acquir Immune Defic Syndr

Retrieve available abstracts of 375 articles:
HTML format



Single Articles


    December 2021
  1. WILSON EC, Turner CM, Sanz-Rodriguez C, Arayasirikul S, et al
    Expanding the Pie-Differentiated PrEP Delivery Models to Improve PrEP Uptake in the San Francisco Bay Area.
    J Acquir Immune Defic Syndr. 2021;88.
    PubMed     Abstract available


  2. SEVELIUS JM, Glidden DV, Deutsch M, Welborn L, et al
    Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California.
    J Acquir Immune Defic Syndr. 2021;88.
    PubMed     Abstract available


  3. RICE E, Wilder B, Onasch-Vera L, DiGuiseppi G, et al
    A Peer-Led, Artificial Intelligence-Augmented Social Network Intervention to Prevent HIV Among Youth Experiencing Homelessness.
    J Acquir Immune Defic Syndr. 2021;88.
    PubMed     Abstract available


  4. HOLLOWAY IW, Beltran R, Shah SV, Cordero L, et al
    Structural Syndemics and Antiretroviral Medication Adherence Among Black Sexual Minority Men Living With HIV.
    J Acquir Immune Defic Syndr. 2021;88.
    PubMed     Abstract available


  5. ARNOLD EA, Saberi P, Wong JO, Pollack LM, et al
    We are Family: A Feasibility and Acceptability Study of an HIV Prevention Intervention With the House Ball and Gay Family Communities.
    J Acquir Immune Defic Syndr. 2021;88.
    PubMed     Abstract available


  6. LIGHTFOOT M, Milburn N, Loeb Stanga L
    Addressing Health Disparities in HIV: Introduction to the Special Issue.
    J Acquir Immune Defic Syndr. 2021;88.
    PubMed     Abstract available


  7. LORENZ DR, Mukerji SS, Misra V, Uno H, et al
    Predictors of Transition to Frailty in Middle-Aged and Older People With HIV: A Prospective Cohort Study.
    J Acquir Immune Defic Syndr. 2021;88:518-527.
    PubMed     Abstract available


  8. SUPANAN R, Han WM, Harnpariphan W, Ueaphongsukkit T, et al
    Brief Report: HCV Universal Test-and-Treat With Direct Acting Antivirals for Prisoners With or Without HIV: A Prison Health Care Workers-Led Model for HCV Microelimination in Thailand.
    J Acquir Immune Defic Syndr. 2021;88:465-469.
    PubMed     Abstract available


  9. WAGNER Z, Mukasa B, Nakakande J, Stecher C, et al
    Impact of the COVID-19 Pandemic on Use of HIV Care, Antiretroviral Therapy Adherence, and Viral Suppression: An Observational Cohort Study From Uganda.
    J Acquir Immune Defic Syndr. 2021;88:448-456.
    PubMed     Abstract available


  10. FRIEDMAN MR, Kempf MC, Benning L, Adimora AA, et al
    Prevalence of COVID-19-Related Social Disruptions and Effects on Psychosocial Health in a Mixed-Serostatus Cohort of Men and Women.
    J Acquir Immune Defic Syndr. 2021;88:426-438.
    PubMed     Abstract available


  11. EKSTRAND ML, Heylen E, Gandhi M, Steward WT, et al
    COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns.
    J Acquir Immune Defic Syndr. 2021;88:421-425.
    PubMed     Abstract available


  12. BATES L, Honeycutt A, Bass S, Green TA, et al
    Updated Estimates of the Number of Men Who Have Sex With Men (MSM) With Indications for HIV Pre-exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2021;88:e28-e30.
    PubMed    


  13. KOAY WLA, Prabhakar S, Neilan A, Meyers J, et al
    Brief Report: Supporting Access to HIV Care for Children and Youth During the COVID-19 Pandemic With Telemedicine and Rideshare.
    J Acquir Immune Defic Syndr. 2021;88:384-388.
    PubMed     Abstract available


  14. REES H, Chersich MF, Munthali RJ, Brumskine W, et al
    HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use.
    J Acquir Immune Defic Syndr. 2021;88:376-383.
    PubMed     Abstract available


    November 2021
  15. DONG T, Rana MN, Longenecker CT, Rajagopalan S, et al
    Machine Learning Estimation of Low-Density Lipoprotein Cholesterol in Women with and without HIV.
    J Acquir Immune Defic Syndr. 2021 Nov 22. pii: 00126334-900000000-95759.
    PubMed     Abstract available


  16. CHAI PR, Mohamed Y, Bustamante MJ, Goodman GR, et al
    DigiPrEP: A pilot trial to evaluate the feasibility, acceptability, and accuracy of a digital pill system to measure PrEP adherence in men who have sex with men who use substances.
    J Acquir Immune Defic Syndr. 2021 Nov 8. pii: 00126334-900000000-95762.
    PubMed     Abstract available


  17. CAPOFERRI AA, Redd AD, Gocke CD, Clark LR, et al
    Rebound HIV viremia with meningoencephalitis following antiretroviral therapy interruption after allogeneic bone marrow transplant.
    J Acquir Immune Defic Syndr. 2021 Nov 8. pii: 00126334-900000000-95761.
    PubMed     Abstract available


  18. CALZA L, Legnani G, Fulgaro C, Verucchi G, et al
    CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR DOLUTEGRAVIR/LAMIVUDINE/ABACAVIR.
    J Acquir Immune Defic Syndr. 2021 Nov 5. pii: 00126334-900000000-95763.
    PubMed    


  19. FONG Y, Markby J, Andreotti M, Beck I, et al
    Diagnostic accuracy of dried plasma spot specimens for HIV-1 viral load testing: a systematic review and meta-analysis.
    J Acquir Immune Defic Syndr. 2021 Nov 2. pii: 00126334-900000000-95767.
    PubMed     Abstract available


  20. OPOLLO V, Nyakeriga E, Kingwara L, Sila A, et al
    Evaluation of the Performance of OraQuick(R) Rapid HIV-1/2 Test among decedents in Kisumu, Kenya.
    J Acquir Immune Defic Syndr. 2021 Nov 2. pii: 00126334-900000000-95766.
    PubMed     Abstract available


  21. MOMPER JD, Wang J, Stek A, Shapiro DE, et al
    Pharmacokinetics of atazanavir boosted with cobicistat in pregnant and postpartum women with HIV.
    J Acquir Immune Defic Syndr. 2021 Nov 2. pii: 00126334-900000000-95765.
    PubMed     Abstract available


  22. MATTHEWS RP, Jackson Rudd D, Zhang S, Fillgrove KL, et al
    Safety and Pharmacokinetics of Once-Daily Multiple-Dose Administration of Islatravir in Adults Without HIV.
    J Acquir Immune Defic Syndr. 2021;88:314-321.
    PubMed     Abstract available


  23. GIACOMELLI A, Bonazzetti C, Conti F, Pezzati L, et al
    Brief Report: Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic.
    J Acquir Immune Defic Syndr. 2021;88:299-304.
    PubMed     Abstract available


  24. KATUREEBE C, Ashburn K, Machekano R, Gill MM, et al
    Developing and Validating an Effective Pediatric and Adolescent HIV Testing Eligibility Screening Tool for High-Volume Entry Points in Uganda.
    J Acquir Immune Defic Syndr. 2021;88:290-298.
    PubMed     Abstract available


  25. ZHU W, Huang YA, Kourtis AP, Hoover KW, et al
    Trends in the Number and Characteristics of HIV Pre-Exposure Prophylaxis Providers in the United States, 2014-2019.
    J Acquir Immune Defic Syndr. 2021;88:282-289.
    PubMed     Abstract available


  26. DAUBERT E, French AL, Burgess HJ, Sharma A, et al
    Association of poor sleep with depressive and anxiety symptoms by HIV disease status: Women's Interagency HIV Study (WIHS).
    J Acquir Immune Defic Syndr. 2021 Nov 1. pii: 00126334-900000000-95764.
    PubMed     Abstract available


    October 2021
  27. HOJILLA JC, Hurley LB, Marcus JL, Satre DD, et al
    The HIV preexposure prophylaxis (PrEP) continuum of care among transgender individuals in an integrated healthcare system.
    J Acquir Immune Defic Syndr. 2021 Oct 28. pii: 00126334-900000000-95770.
    PubMed    


  28. SAXBY K, Chan C, Bavinton BR
    Structural stigma and sexual health disparities among gay, bisexual, and other men who have sex with men in Australia.
    J Acquir Immune Defic Syndr. 2021 Oct 28. pii: 00126334-900000000-95769.
    PubMed     Abstract available


  29. NYANDIKO W, Holland S, Vreeman R, DeLong AK, et al
    HIV-1 Treatment Failure, Drug Resistance and Clinical Outcomes in Perinatally-Infected Children and Adolescents Failing 1st-Line Antiretroviral Therapy in Western Kenya.
    J Acquir Immune Defic Syndr. 2021 Oct 28. pii: 00126334-900000000-95768.
    PubMed     Abstract available


  30. GIBBS A, Reddy T, Closson K, Cawood C, et al
    Intimate partner violence and the HIV care and treatment cascade among adolescent girls and young women in DREAMS, South Africa.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95776.
    PubMed     Abstract available


  31. ZANG X, Mah C, Linh Quan AM, Min JE, et al
    Human Immunodeficiency Virus transmission by HIV risk group and along the HIV care continuum: A contrast of six US cities.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95775.
    PubMed     Abstract available


  32. SYED MA, Khan A, Chaudhry A, Baig MA, et al
    An Epidemic of Pediatric HIV from Reuse of Infusion Equipment in Pakistan.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95774.
    PubMed     Abstract available


  33. VOLPE LJ, Powis KM, Legbedze J, Sun S, et al
    A counseling and monitoring approach for supporting breastfeeding women living with HIV in Botswana.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95773.
    PubMed    


  34. CONROY AA, Jain JP, Sheira L, Frongillo EA, et al
    Mental Health Mediates the Association between Gender-Based Violence and HIV Treatment Engagement in U.S. Women.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95772.
    PubMed     Abstract available


  35. SUEN LW, Davidson PJ, Browne EN, Lambdin BH, et al
    Effect of an Unsanctioned Safe Consumption Site in the United States on Syringe Sharing, Rushed Injections, and Isolated Injection Drug Use: A Longitudinal Cohort Analysis.
    J Acquir Immune Defic Syndr. 2021 Oct 27. pii: 00126334-900000000-95771.
    PubMed     Abstract available


  36. NANYONGA SM, Kitutu FE, Kalyango J, Frank M, et al
    High burden of adverse drug reactions to Isoniazid Preventive Therapy in people living with HIV at three tertiary hospitals in Uganda: associated factors.
    J Acquir Immune Defic Syndr. 2021 Oct 21. pii: 00126334-900000000-95777.
    PubMed     Abstract available


  37. ROUSSEAU RK, Walmsley SL, Lee T, Rosenes R, et al
    A randomized, blinded, placebo-controlled trial of De Simone formulation probiotic during HIV-associated suboptimal CD4+ T cell recovery.
    J Acquir Immune Defic Syndr. 2021 Oct 20. pii: 00126334-900000000-95779.
    PubMed     Abstract available


  38. SHAFFER D, Kumwenda J, Chen H, Akelo V, et al
    Brief Report: No Differences Between Lopinavir/ritonavir and non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)
    J Acquir Immune Defic Syndr. 2021 Oct 19. pii: 00126334-900000000-95780.
    PubMed     Abstract available


  39. SAHAGUN SJ, Yeramosu T, Purdy JB, Reynolds JC, et al
    Associations between Central Obesity and Life-Long Antiviral Therapy in Adults Living with HIV Acquired from Early Childhood.
    J Acquir Immune Defic Syndr. 2021 Oct 19. pii: 00126334-900000000-95778.
    PubMed     Abstract available


  40. SCHURMANN D, Rudd DJ, Schaeffer A, De Lepeleire I, et al
    Single oral doses of MK-8507, a novel non-nucleoside reverse transcriptase inhibitor, suppress HIV-1 RNA for a week.
    J Acquir Immune Defic Syndr. 2021 Oct 13. pii: 00126334-900000000-95781.
    PubMed     Abstract available


  41. PYRA M, Brewer R, Rusie L, Kline J, et al
    Long-term HIV Pre-exposure Prophylaxis Trajectories Among Racial & Ethnic Minority Patients: Short, Declining, & Sustained Adherence.
    J Acquir Immune Defic Syndr. 2021 Oct 9. pii: 00126334-900000000-95782.
    PubMed     Abstract available


  42. LONGINO AA, Paul R, Wang Y, Lama JR, et al
    HIV disease dynamics, markers of inflammation and CNS injury during primary HIV infection and their relationship to cognitive performance.
    J Acquir Immune Defic Syndr. 2021 Oct 7. pii: 00126334-900000000-95788.
    PubMed     Abstract available


  43. TRUJILLO L, Robbins T, Morris E, Sionean C, et al
    Material hardship and association with sexual risk behavior among adolescent sexual minority males in 3 U.S. cities - National HIV Behavioral Surveillance-Young Men who Have Sex with Men, 2015.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95789.
    PubMed     Abstract available


  44. KAPLAN SR, Escudero JN, Mecha J, Richardson BA, et al
    Interferon gamma release-assay and tuberculin skin test performance in pregnant women living with and without HIV.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95787.
    PubMed     Abstract available


  45. DIAZ RS, Grangeiro A, Estevam DL, Galinskas J, et al
    Pre-exposure prophylaxis failure with a multiple drug-resistant HIV-1 clade C virus in Brazil.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95786.
    PubMed    


  46. FAZELI PL, Woods SP, Lambert CC, Li W, et al
    Differential Associations Between BDNF and Memory Across Older Black and White Adults with HIV Disease.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95784.
    PubMed     Abstract available


  47. HELLER T, Wallrauch C, Gumulira J, Rambiki K, et al
    Low CD4 counts despite effective ART in hospitalized Malawian HIV+/COVID+ co-infected patients.
    J Acquir Immune Defic Syndr. 2021 Oct 6. pii: 00126334-900000000-95783.
    PubMed    


  48. DELLE DONNE V, Massaroni V, Ciccarelli N, Lombardi F, et al
    Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV.
    J Acquir Immune Defic Syndr. 2021;88:e11-e14.
    PubMed    


  49. ALESSANDRI-GRADT E, Unal G, Baron A, Leoz M, et al
    Performance Analysis of Three Commercial Kits Designed for RNA Quantification of HIV-1 Group O Variants.
    J Acquir Immune Defic Syndr. 2021;88:220-227.
    PubMed     Abstract available


  50. CAMPBELL L, Barbini B, Burling K, Cromarty B, et al
    Safety of Tenofovir Alafenamide in People With HIV Who Experienced Proximal Renal Tubulopathy on Tenofovir Disoproxil Fumarate.
    J Acquir Immune Defic Syndr. 2021;88:214-219.
    PubMed     Abstract available


  51. WOMACK JA, Murphy TE, Ramsey C, Bathulapalli H, et al
    Brief Report: Are Serious Falls Associated With Subsequent Fragility Fractures Among Veterans Living With HIV?
    J Acquir Immune Defic Syndr. 2021;88:192-196.
    PubMed     Abstract available


  52. HULL SJ, Tessema H, Thuku J, Scott RK, et al
    Providers PrEP: Identifying Primary Health care Providers' Biases as Barriers to Provision of Equitable PrEP Services.
    J Acquir Immune Defic Syndr. 2021;88:165-172.
    PubMed     Abstract available


  53. LEMOS MP, Nandi V, Dragavon J, Fleming I, et al
    HIV-1 Nucleic Acids Identify Rectal HIV Exposures in Self-Collected Rectal Swabs, Whereas Y-Chromosome Single Tandem Repeat Mixtures Are Not Reliable Biomarkers of Condomless Receptive Anal Intercourse.
    J Acquir Immune Defic Syndr. 2021;88:138-148.
    PubMed     Abstract available


    September 2021
  54. ERLY S, Khosropour CM, Hajat A, Sharma M, et al
    Characterization of the Population Impacted by the 6-Month Recertification Criterion of the Ryan White HIV/AIDS Program's AIDS Drug Assistance Program in Washington State, 2017-2019.
    J Acquir Immune Defic Syndr. 2021 Sep 30. pii: 00126334-900000000-95790.
    PubMed     Abstract available


  55. RAJU S, Astemborski J, Drummond MB, Ramamurthi HC, et al
    HIV is Associated with Impaired Pulmonary Diffusing Capacity Independent of Emphysema.
    J Acquir Immune Defic Syndr. 2021 Sep 24. pii: 00126334-900000000-95797.
    PubMed     Abstract available


  56. AUNG S, Hardy N, Chrysanthopoulou SA, Kyaw A, et al
    Stigma Determines Antiretroviral Adherence in Adults with HIV in Myanmar.
    J Acquir Immune Defic Syndr. 2021 Sep 17. pii: 00126334-900000000-95804.
    PubMed     Abstract available


  57. MURNANE PM, Ayieko J, Vittinghoff E, Gandhi M, et al
    Machine learning algorithms using routinely collected data do not adequately predict viremia to inform targeted services in postpartum women living with HIV.
    J Acquir Immune Defic Syndr. 2021 Sep 14. pii: 00126334-900000000-95807.
    PubMed     Abstract available


  58. HOGH J, Gelpi M, Skovsgaard MH, Afzal S, et al
    HIV infection is associated with type 2 diabetes mellitus.
    J Acquir Immune Defic Syndr. 2021 Sep 14. pii: 00126334-900000000-95806.
    PubMed    


  59. SORENSEN EW, Gelpi M, Knudsen AD, Benfield T, et al
    Switch To Insti, But Not Long-Term Stable Insti, Is Associated With Excess Weight Gain In People Living With Hiv.
    J Acquir Immune Defic Syndr. 2021 Sep 14. pii: 00126334-900000000-95805.
    PubMed    


  60. KERSCHBERGER B, Aung A, Mpala Q, Ntshalintshali N, et al
    Predicting, diagnosing and treating acute and early HIV infection in a public sector facility in Eswatini.
    J Acquir Immune Defic Syndr. 2021 Sep 3. pii: 00126334-900000000-95815.
    PubMed     Abstract available


  61. HAGINS D, Kumar P, Saag M, Wurapa AK, et al
    Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study.
    J Acquir Immune Defic Syndr. 2021;88:86-95.
    PubMed     Abstract available


  62. GUTIERREZ J, Porras TN, Yoo-Jeong M, Khasiyev F, et al
    Cerebrovascular Contributions to Neurocognitive Disorders in People Living With HIV.
    J Acquir Immune Defic Syndr. 2021;88:79-85.
    PubMed     Abstract available


  63. MOLDT B, Parvangada A, Martin R, Pace C, et al
    Evaluation of Broadly Neutralizing Antibody Sensitivity by Genotyping and Phenotyping for Qualifying Participants to HIV Clinical Trials.
    J Acquir Immune Defic Syndr. 2021;88:61-69.
    PubMed     Abstract available


  64. SEWELL WC, Powell VE, Ball-Burack M, Mayer KH, et al
    Brief Report: "I Didn't Really Have a Primary Care Provider Until I Got PrEP": Patients' Perspectives on HIV Preexposure Prophylaxis as a Gateway to Health Care.
    J Acquir Immune Defic Syndr. 2021;88:31-35.
    PubMed     Abstract available


  65. MALONE J, Reisner SL, Cooney EE, Poteat T, et al
    Perceived HIV Acquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States.
    J Acquir Immune Defic Syndr. 2021;88:10-18.
    PubMed     Abstract available


  66. CHANG JJ, Bruxvoort K, Chen LH, Akhavan B, et al
    Brief Report: COVID-19 Testing, Characteristics, and Outcomes Among People Living With HIV in an Integrated Health System.
    J Acquir Immune Defic Syndr. 2021;88:1-5.
    PubMed     Abstract available


  67. SARDA V, Gomez C, Soria J, Sarmiento J, et al
    Factors Associated With Coronavirus Disease 2019 Morbidity in a Cohort of People Living With Human Immunodeficiency Virus.
    J Acquir Immune Defic Syndr. 2021;88:e7-e9.
    PubMed    


  68. CICCULLO A, D'Angelillo A, Iannone V, Farinacci D, et al
    Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV.
    J Acquir Immune Defic Syndr. 2021;88:e5-e6.
    PubMed    


    August 2021
  69. BENNETT CL, Ogele E, Pettit NR, Bischof JJ, et al
    Multi-Center Study of Outcomes Among Persons with HIV who Presented to US Emergency Departments with suspected SARS-CoV-2.
    J Acquir Immune Defic Syndr. 2021 Aug 31. pii: 00126334-900000000-95816.
    PubMed     Abstract available


  70. BROWN LK, Chernoff M, Kennard BD, Emslie GJ, et al
    Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living with HIV in the United States.
    J Acquir Immune Defic Syndr. 2021 Aug 30. pii: 00126334-900000000-95818.
    PubMed     Abstract available


  71. TEMBO TA, Simon KR, Kim MH, Chikoti C, et al
    Pilot-testing a Blended Learning Package for Health Care Workers to Improve Index Testing Services in Southern Malawi: An Implementation Science Study.
    J Acquir Immune Defic Syndr. 2021 Aug 30. pii: 00126334-900000000-95817.
    PubMed     Abstract available


  72. NGURE K, Mugo NR, Bukusi EA, Kiptinness C, et al
    Pills, injections, rings or implants? PrEP formulation preferences of PrEP-experienced African women for HIV prevention.
    J Acquir Immune Defic Syndr. 2021 Aug 25. pii: 00126334-900000000-95819.
    PubMed    


  73. DAT VQ, Lyss S, Hoai Dung NT, Hung LM, et al
    Prevalence of advanced HIV disease, cryptococcal antigenemia and suboptimal clinical outcomes among those enrolled in care in Vietnam.
    J Acquir Immune Defic Syndr. 2021 Aug 20. pii: 00126334-900000000-95822.
    PubMed     Abstract available


  74. MCCREE DH, Beer L, Jeffries WL 4th, Tie Y, et al
    Sociodemographic Correlates of Self-reported Discrimination in HIV Health Care Settings among Persons with Diagnosed HIV in the United States, Medical Monitoring Project, 2018-2019.
    J Acquir Immune Defic Syndr. 2021 Aug 20. pii: 00126334-900000000-95821.
    PubMed     Abstract available


  75. CICCULLO A, Borghi V, Giacomelli A, Cossu MV, et al
    Five years with dolutegravir plus lamivudine as a switch strategy: much more than a positive finding.
    J Acquir Immune Defic Syndr. 2021 Aug 20. pii: 00126334-900000000-95820.
    PubMed     Abstract available


  76. ORKIN C, Ajana F, Kityo C, Koenig E, et al
    Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials.
    J Acquir Immune Defic Syndr. 2021 Aug 20. pii: 00126334-900000000-95811.
    PubMed     Abstract available


  77. KRENISKE P, Mellins CA, Dolezal C, Morrison C, et al
    Predictors of attempted suicide among youth living with perinatal HIV infection and perinatal HIV exposed uninfected counterparts.
    J Acquir Immune Defic Syndr. 2021 Aug 16. pii: 00126334-900000000-95824.
    PubMed     Abstract available


  78. LUCKETT PH, Paul RH, Hannon K, Lee JJ, et al
    Modeling the Effects of HIV and Aging on Resting-State Networks using Machine Learning.
    J Acquir Immune Defic Syndr. 2021 Aug 16. pii: 00126334-900000000-95823.
    PubMed     Abstract available


  79. MUCCINI C, Pinyakorn S, Sirivichayakul S, Kroon E, et al
    Brief Report: Prevalence Trend of Transmitted Drug Resistance in a Prospective Cohort of Thai People With Acute HIV Infection.
    J Acquir Immune Defic Syndr. 2021;87:1173-1177.
    PubMed     Abstract available


  80. FISHER MC, Fazzari MJ, Hanna DB, Patel VV, et al
    Brief Report: Acute Kidney Injury in People Living With HIV Hospitalized With Coronavirus Disease 2019: Clinical Characteristics and Outcomes.
    J Acquir Immune Defic Syndr. 2021;87:1167-1172.
    PubMed     Abstract available


  81. GILLES I, Lesage S, Barbieux C, Alessandrini M, et al
    Brief Report: Representations and Willingness of People Living With HIV in Switzerland to Participate in HIV Cure Trials: The Case of Gene-Modified Cell Therapies.
    J Acquir Immune Defic Syndr. 2021;87:1154-1160.
    PubMed     Abstract available


  82. JONGEN VW, Zimmermann HML, Boyd A, Hoornenborg E, et al
    Transient Changes in Preexposure Prophylaxis Use and Daily Sexual Behavior After the Implementation of COVID-19 Restrictions Among Men Who Have Sex With Men.
    J Acquir Immune Defic Syndr. 2021;87:1111-1118.
    PubMed     Abstract available


  83. DETTINGER JC, Pintye J, Dollah A, Awuor M, et al
    "What is this PrEP?"- Sources and accuracy of HIV Pre-Exposure Prophylaxis (PrEP) awareness among adolescent girls and young women attending family planning and maternal child health clinics in Western Kenya.
    J Acquir Immune Defic Syndr. 2021 Aug 9. pii: 00126334-900000000-95825.
    PubMed     Abstract available


  84. FRENKEL LM, Leavitt Morrison R, Fuller TL, Isabel Gouvea M, et al
    Vaginal Viral Shedding with Undetectable Plasma HIV Viral Load in Pregnant Women Receiving Two Different Antiretroviral Regimens: A Randomized Clinical Trial.
    J Acquir Immune Defic Syndr. 2021 Aug 7. pii: 00126334-900000000-95826.
    PubMed     Abstract available


  85. LE GUILLOU A, Buchbinder S, Scott H, Liu A, et al
    Population Impact and Efficiency of Improvements to HIV PrEP Under Conditions of High ART Coverage among San Francisco Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2021 Aug 5. pii: 00126334-900000000-95830.
    PubMed     Abstract available


  86. WIGGILL T, Mayne E, Perner Y, Vaughan J, et al
    Changing patterns of Lymphoma in the Anti-Retroviral Therapy Era in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2021 Aug 5. pii: 00126334-900000000-95829.
    PubMed     Abstract available


  87. BROPHY JE, Lessler J, Ssekubugu R, Kennedy CE, et al
    Prevalence of untreated HIV and associated risk behaviors among the sexual partners of recent migrants and long-term residents in Rakai, Uganda.
    J Acquir Immune Defic Syndr. 2021 Aug 5. pii: 00126334-900000000-95828.
    PubMed     Abstract available


  88. DAILEY A, Johnson AS, Hu X, Gant Z, et al
    Trends in HIV Care Outcomes Among Adults and Adolescents - 33 Jurisdictions, United States, 2014-2018.
    J Acquir Immune Defic Syndr. 2021 Aug 4. pii: 00126334-900000000-95827.
    PubMed     Abstract available


  89. WEST CA, Chang GC, W Currie D, Bray R, et al
    Unawareness of HIV Infection Among Men Aged 15-59 Years in 13 Sub-Saharan African Countries: Findings From the Population-Based HIV Impact Assessments, 2015-2019.
    J Acquir Immune Defic Syndr. 2021;87.
    PubMed     Abstract available


  90. VOETSCH AC, Duong YT, Stupp P, Saito S, et al
    HIV-1 Recent Infection Testing Algorithm With Antiretroviral Drug Detection to Improve Accuracy of Incidence Estimates.
    J Acquir Immune Defic Syndr. 2021;87.
    PubMed     Abstract available


  91. DOMAOAL RA, Sleeman K, Sawadogo S, Dzinamarira T, et al
    Successful Use of Near Point-of-Care Early Infant Diagnosis in NAMPHIA to Improve Turnaround Times in a National Household Survey.
    J Acquir Immune Defic Syndr. 2021;87.
    PubMed     Abstract available


  92. BRAY R, Palma AM, Philip NM, Brown K, et al
    Is Interview Length Associated With Blood Test Participation? Evidence From Three Population-Based HIV Impact Assessment Surveys Conducted From 2016 to 2017.
    J Acquir Immune Defic Syndr. 2021;87.
    PubMed     Abstract available


  93. REID G, Voetsch AC, Stupp P, McCracken S, et al
    Improving Sampling Efficiency for Determining Pediatric HIV Prevalence in National Surveys: Evidence From 8 Sub-Saharan African Countries.
    J Acquir Immune Defic Syndr. 2021;87.
    PubMed     Abstract available


  94. JAHUN I, Greby SM, Adesina T, Agbakwuru C, et al
    Lessons From Rapid Field Implementation of an HIV Population-Based Survey in Nigeria, 2018.
    J Acquir Immune Defic Syndr. 2021;87.
    PubMed     Abstract available


  95. METZ M, Smith R, Mitchell R, Duong YT, et al
    Data Architecture to Support Real-Time Data Analytics for the Population-Based HIV Impact Assessments.
    J Acquir Immune Defic Syndr. 2021;87.
    PubMed     Abstract available


  96. PATEL HK, Duong YT, Birhanu S, Dobbs T, et al
    A Comprehensive Approach to Assuring Quality of Laboratory Testing in HIV Surveys: Lessons Learned From the Population-Based HIV Impact Assessment Project.
    J Acquir Immune Defic Syndr. 2021;87.
    PubMed     Abstract available


  97. SACHATHEP K, Radin E, Hladik W, Hakim A, et al
    Population-Based HIV Impact Assessments Survey Methods, Response, and Quality in Zimbabwe, Malawi, and Zambia.
    J Acquir Immune Defic Syndr. 2021;87.
    PubMed     Abstract available


  98. PORTER L, Bello G, Nkambule R, Justman J, et al
    HIV General Population Surveys: Shedding Light on the Status of HIV Epidemics and Informing Future Actions.
    J Acquir Immune Defic Syndr. 2021;87.
    PubMed     Abstract available


  99. HOQUE TMD, Cattin A, Whyte-Allman SK, Winchester L, et al
    Antiretroviral Drug Transporters and Metabolic Enzymes in Circulating Monocytes and Monocyte-Derived Macrophages of ART-Treated People Living With HIV and HIV-Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2021;87:1093-1101.
    PubMed     Abstract available


  100. TAIWO BO, Kuti KM, Kuhns LM, Omigbodun O, et al
    Effect of Text Messaging Plus Peer Navigation on Viral Suppression Among Youth With HIV in the iCARE Nigeria Pilot Study.
    J Acquir Immune Defic Syndr. 2021;87:1086-1092.
    PubMed     Abstract available


  101. SAMBOJU V, Cobigo Y, Paul R, Naasan G, et al
    Cerebrovascular Disease Correlates With Longitudinal Brain Atrophy in Virally Suppressed Older People Living With HIV.
    J Acquir Immune Defic Syndr. 2021;87:1079-1085.
    PubMed     Abstract available


  102. HERMANS LE, Nijhuis M, Tempelman HA, Houts T, et al
    Point-of-Care Detection of Nonadherence to Antiretroviral Treatment for HIV-1 in Resource-Limited Settings Using Drug Level Testing for Efavirenz, Lopinavir, and Dolutegravir: A Validation and Pharmacokinetic Simulation Study.
    J Acquir Immune Defic Syndr. 2021;87:1072-1078.
    PubMed     Abstract available


  103. BIRX D, Zaidi I
    Forward: Measuring Progress Toward Epidemic Control.
    J Acquir Immune Defic Syndr. 2021;87.
    PubMed    


    July 2021
  104. SHRADER CH, Arroyo-Flores J, Stoler J, Skvoretz J, et al
    The association between social and spatial closeness with PrEP conversations among Latino men who have sex with men.
    J Acquir Immune Defic Syndr. 2021 Jul 31. pii: 00126334-900000000-95832.
    PubMed     Abstract available


  105. KAMIS KF, Barbera L, Abdo M, Rowan SE, et al
    Risk factors for hospitalization in people with HIV and COVID-19.
    J Acquir Immune Defic Syndr. 2021 Jul 30. pii: 00126334-900000000-95834.
    PubMed    


  106. CHAISSON LH, Saraceni V, Cohn S, Cavalcante SC, et al
    Yield of repeat tuberculin skin testing for people living with HIV in Brazil.
    J Acquir Immune Defic Syndr. 2021 Jul 30. pii: 00126334-900000000-95833.
    PubMed     Abstract available


  107. SCHLENKER NW, Irvin NA, Galetto GG, Dashler GM, et al
    Identifying Missed Opportunities in the Prevention of Acute HIV Infection - The Need to Provide Pre-Exposure Prophylaxis Referrals to Emergency Department Patients with Increased Risk for Acquiring HIV.
    J Acquir Immune Defic Syndr. 2021 Jul 27. pii: 00126334-900000000-95836.
    PubMed    


  108. HAKIM AJ, Tippett Barr BA, Kinchen S, Musuka G, et al
    Progress toward the 90-90-90 HIV targets in Zimbabwe and identifying those left behind.
    J Acquir Immune Defic Syndr. 2021 Jul 24. pii: 00126334-900000000-95837.
    PubMed     Abstract available


  109. LYSS SB, Zhang T, Oster AM
    HIV Diagnoses Among Persons Who Inject Drugs, by Urban-Rural Classification - United States, 2010-2018.
    J Acquir Immune Defic Syndr. 2021 Jul 22. pii: 00126334-900000000-95839.
    PubMed     Abstract available


  110. CHEN YT, Duncan DT, Del Vecchio N, Timmins L, et al
    COVID-19 related stressors, sex behaviors, and HIV status neutral care among Black men who have sex with men and transgender women in Chicago, USA.
    J Acquir Immune Defic Syndr. 2021 Jul 22. pii: 00126334-900000000-95838.
    PubMed     Abstract available


  111. JOHNSTON CD, Siegler EL, Rice MC, Derry HM, et al
    Urine Cell-Free Mitochondrial DNA as a Marker of Weight Loss and Body Composition in Older Adults with HIV.
    J Acquir Immune Defic Syndr. 2021 Jul 19. pii: 00126334-900000000-95842.
    PubMed     Abstract available


  112. MANZA-A AGOVI A, Anikpo I, Cvitanovich M, Fasanmi EO, et al
    Brief Report: HIV Pre-Exposure Prophylaxis Prescribing in an Urban Safety-Net Health System.
    J Acquir Immune Defic Syndr. 2021 Jul 19. pii: 00126334-900000000-95841.
    PubMed    


  113. SALAMA E, Hill L, Patel N, Best BM, et al
    Pharmacokinetics of bictegravir and tenofovir in combination with darunavir/cobicistat in treatment-experienced persons with HIV.
    J Acquir Immune Defic Syndr. 2021 Jul 19. pii: 00126334-900000000-95840.
    PubMed     Abstract available


  114. COPELAND NK, Eller MA, Kim D, Creegan M, et al
    Increased Inflammation and Liver Disease in HIV/HBV-coinfected Individuals.
    J Acquir Immune Defic Syndr. 2021 Jul 14. pii: 00126334-900000000-95846.
    PubMed     Abstract available


  115. CELERINO DA SILVA R, Pereira Alves NM, Gondim Silva ML, Agrelli A, et al
    Polymorphisms in TNF-alpha/TNFR1 pathway genes are associated with CD4+ T cells recovery in HIV-1-infected individuals on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2021 Jul 14. pii: 00126334-900000000-95845.
    PubMed     Abstract available


  116. LARA-PAEZ G, Zuazo M, Blumenthal J, Coyne CJ, et al
    HIV and HCV Screening in the Emergency Department and Linkage to Care during COVID-19: Challenges and Solutions.
    J Acquir Immune Defic Syndr. 2021 Jul 14. pii: 00126334-900000000-95844.
    PubMed     Abstract available


  117. KALICHMAN SC, Kalichman MO, Eaton LA
    Undisclosed HIV Status to Sex Partners and Its Unintended Consequences in the Era of Undetectable = Untransmittable.
    J Acquir Immune Defic Syndr. 2021 Jul 13. pii: 00126334-900000000-95843.
    PubMed     Abstract available


  118. LELLOUCHE L, Gutierrez LA, Leclercq P, Zaegel-Faucher O, et al
    Frailty in Aging People Living With HIV: a matched controlled Study.
    J Acquir Immune Defic Syndr. 2021 Jul 6. pii: 00126334-900000000-95850.
    PubMed     Abstract available


  119. LUAN H, Song I, Fiellin DA, Ransome Y, et al
    HIV infection prevalence significantly intersects with COVID-19 infection at the area-level: a USA county-level analysis.
    J Acquir Immune Defic Syndr. 2021 Jul 6. pii: 00126334-900000000-95849.
    PubMed     Abstract available


  120. ELLSWORTH GB, Stier EA, Chiao EY, Lensing SY, et al
    Xpert HPV as a Screening Tool for Anal Histologic High-Grade Squamous Intraepithelial Lesions in Women Living With HIV.
    J Acquir Immune Defic Syndr. 2021;87:978-984.
    PubMed     Abstract available


  121. GRANDE M, Mawandia S, Bakae O, Tau L, et al
    Intensified Assisted Partner Notification Implementation in Botswana Increased Partner Identification but Not HIV Case-Finding: Findings Highlight the Need for Improved Data Monitoring.
    J Acquir Immune Defic Syndr. 2021;87:951-958.
    PubMed     Abstract available


    June 2021
  122. GIACOMELLI A, Cozzi-Lepri A, Cingolani A, Tavelli A, et al
    Does syphilis increase the risk of HIV-RNA elevation >200 copies/mL in HIV positive patients under effective antiretroviral treatment? Data from the ICONA cohort.
    J Acquir Immune Defic Syndr. 2021 Jun 15. pii: 00126334-900000000-95862.
    PubMed     Abstract available


  123. PANTAZIS N, Rosinska M, VAN Sighem A, Quinten C, et al
    Discriminating between pre-migration and post-migration HIV acquisition using surveillance data.
    J Acquir Immune Defic Syndr. 2021 Jun 15. pii: 00126334-900000000-95861.
    PubMed     Abstract available


  124. EL-FAR M, Hanna DB, Durand M, Larouche-Anctil E, et al
    Subclinical carotid artery atherosclerosis is associated with increased expression of peripheral blood IL-32 isoforms among women living with HIV.
    J Acquir Immune Defic Syndr. 2021 Jun 14. pii: 00126334-900000000-95860.
    PubMed     Abstract available


  125. SILHOL R, Coupland H, Baggaley RF, Miller L, et al
    What is the burden of heterosexually-acquired HIV due to HSV-2? Global and regional model-based estimates of the proportion and number of HIV infections attributable to HSV-2 infection.
    J Acquir Immune Defic Syndr. 2021 Jun 9. pii: 00126334-900000000-95864.
    PubMed     Abstract available


  126. FLYNN PM, Taha TE, Cababasay M, Butler K, et al
    Association of Maternal Viral Load and CD4 Count with Perinatal HIV-1 Transmission Risk during Breastfeeding in the PROMISE Postpartum Component.
    J Acquir Immune Defic Syndr. 2021 Jun 8. pii: 00126334-900000000-95865.
    PubMed     Abstract available


  127. CHAWANA TD, Nhachi CFB, Nathoo K, Ngara B, et al
    Ritonavir concentrations in hair predict virologic outcomes in HIV-infected adolescents with virologic failure on atazanavir/ritonavir-based second-line treatment.
    J Acquir Immune Defic Syndr. 2021 Jun 8. pii: 00126334-900000000-95863.
    PubMed     Abstract available


  128. JONES DL, Morgan KE, Martinez PC, Rodriguez VJ, et al
    COVID-19 Burden and Risk Among People With HIV.
    J Acquir Immune Defic Syndr. 2021;87:869-874.
    PubMed     Abstract available


  129. DZIVA CHIKWARI C, Simms V, Kranzer K, Dringus S, et al
    Feasibility and Accuracy of HIV Testing of Children by Caregivers Using Oral Mucosal Transudate HIV Tests.
    J Acquir Immune Defic Syndr. 2021;87:781-788.
    PubMed     Abstract available


    May 2021
  130. VUYLSTEKE B, Reyniers T, Noestlinger C, Smekens T, et al
    Can we predict incorrect PrEP use in high HIV risk situations among Men who have Sex with Men? An analysis of Be-PrEP-ared, the Belgian PrEP demonstration study .
    J Acquir Immune Defic Syndr. 2021 May 31. pii: 00126334-900000000-95868.
    PubMed     Abstract available


  131. BILLOCK RM, Samoff E, Lund JL, Pence BW, et al
    HIV VIRAL SUPPRESSION AND PRE-EXPOSURE PROPHYLAXIS IN HIV AND SYPHILIS CONTACT TRACING NETWORKS: AN ANALYSIS OF DISEASE SURVEILLANCE AND PRESCRIPTION CLAIMS DATA.
    J Acquir Immune Defic Syndr. 2021 May 31. pii: 00126334-900000000-95867.
    PubMed     Abstract available


  132. GUZMAN VA, Cham H, Gutierrez J, Byrd D, et al
    The Longitudinal Effects of Blood Pressure and Hypertension on Neurocognitive Performance in People Living with HIV.
    J Acquir Immune Defic Syndr. 2021 May 31. pii: 00126334-900000000-95866.
    PubMed     Abstract available


  133. MCMILLAN JM, Gill MJ, Power C, Fujiwara E, et al
    Construct and Criterion-Related Validity of the Clinical Frailty Scale in Persons with HIV.
    J Acquir Immune Defic Syndr. 2021 May 28. pii: 00126334-900000000-95871.
    PubMed     Abstract available


  134. JASANTHA O, Kabanda S, Malaba TR, Lesosky M, et al
    Viral load monitoring in pregnancy to predict peripartum viraemia in South Africa.
    J Acquir Immune Defic Syndr. 2021 May 28. pii: 00126334-900000000-95870.
    PubMed     Abstract available


  135. AMELIA DE SOUSA MASCENA VERAS , Roza Saggese GS, Gomez Junior JL, Silveira P, et al
    Young age and sex work are associated with HIV seroconversion among transgender women in Sao Paulo, Brazil.
    J Acquir Immune Defic Syndr. 2021 May 26. pii: 00126334-900000000-95872.
    PubMed     Abstract available


  136. GOENAGA SANCHEZ MA, Rodriguez IA, Equiza J, Echeverria CG, et al
    Prognosis of Stroke Among People Living with HIV and its relationship with admission to specialized Stroke Units.
    J Acquir Immune Defic Syndr. 2021 May 21. pii: 00126334-900000000-95876.
    PubMed    


  137. HAZEN R, Halbur D, Mills B, Kirkham H, et al
    Evaluation of medication therapy issues, resolutions, and adherence among persons with HIV in the pharmacist-led Patient-centered HIV Care Model.
    J Acquir Immune Defic Syndr. 2021 May 20. pii: 00126334-900000000-95875.
    PubMed     Abstract available


  138. FOURMAN LT, Mueller SB, Boutin A, Zheng I, et al
    Placental Vascular Abnormalities in Association with Prenatal and Long-term Health Characteristics Among HIV-Exposed Uninfected Adolescents and Young Adults
    J Acquir Immune Defic Syndr. 2021 May 20. pii: 00126334-900000000-95874.
    PubMed     Abstract available


  139. HENSEN B, Machingura F, Busza J, Birdthistle I, et al
    How can we support the use of oral PrEP among young women who sell sex? A PrEP cascade analysis.
    J Acquir Immune Defic Syndr. 2021 May 19. pii: 00126334-900000000-95869.
    PubMed     Abstract available


  140. FOX MP, Pascoe S, Huber AN, Murphy J, et al
    Short-term Outcomes from a Cluster Randomized Evaluation of Adherence Clubs as Part of Differentiated HIV Care in South Africa.
    J Acquir Immune Defic Syndr. 2021 May 12. pii: 00126334-900000000-95880.
    PubMed     Abstract available


  141. JOHNSON KA, Okochi H, Glidden DV, Gandhi M, et al
    Brief Report: No Difference in Urine Tenofovir Levels in Patients Living with HIV on Unboosted vs Dose-Adjusted Boosted Tenofovir Alafenamide.
    J Acquir Immune Defic Syndr. 2021 May 12. pii: 00126334-900000000-95879.
    PubMed     Abstract available


  142. GRAHAM SM, Maqungo S, Laubscher M, Ferreira N, et al
    Fracture healing in patients with human immunodeficiency virus in South Africa: a prospective cohort study.
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95886.
    PubMed     Abstract available


  143. DRAIN PK, Galagan SR, Govere S, Krows M, et al
    Laboratory Reflex and Clinic-based Point-of-care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality among People Living with HIV.
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95885.
    PubMed     Abstract available


  144. DIAS JP, Haberlen SA, Dobs AS, Lake JE, et al
    Longitudinal changes in sex hormone-binding globulin in men with HIV.
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95884.
    PubMed     Abstract available


  145. JIAMSAKUL A, Boyd M, Choi JY, Edmiston N, et al
    Trends in follow-up visits among people living with HIV - results from the TREAT Asia and Australian HIV Observational Databases (TAHOD and AHOD).
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95883.
    PubMed     Abstract available


  146. HESELTINE T, Murray S, Ortega-Martorell S, Olier I, et al
    Associations of Hepatosteatosis with Cardiovascular Disease in HIV Positive and HIV Negative Patients: The Liverpool HIV-Heart Project.
    J Acquir Immune Defic Syndr. 2021 May 8. pii: 00126334-900000000-95882.
    PubMed     Abstract available


  147. SIRAJEE R, Conroy AL, Namasopo S, Opoka RO, et al
    Growth Faltering and Developmental Delay in HIV-Exposed Uninfected Ugandan Infants: A Prospective Cohort Study.
    J Acquir Immune Defic Syndr. 2021;87:730-740.
    PubMed     Abstract available


  148. GAY CL, Bosch RJ, McKhann A, Moseley KF, et al
    Suspected Immune-Related Adverse Events with an Anti-PD-1 Inhibitor in Healthy People with HIV.
    J Acquir Immune Defic Syndr. 2021 May 1. pii: 00126334-900000000-95887.
    PubMed    


    April 2021
  149. PITPITAN EV, MacKinnon DP, Eaton LA, Smith LR, et al
    Using novel approaches to evaluate behavioral interventions: Overlooked significant HIV prevention effects in HPTN 015 Project EXPLORE.
    J Acquir Immune Defic Syndr. 2021 Apr 20. pii: 00126334-900000000-95892.
    PubMed     Abstract available


  150. ANDERSON AM, Tang B, Vaida F, Mcclernon D, et al
    Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study.
    J Acquir Immune Defic Syndr. 2021 Apr 20. pii: 00126334-900000000-95891.
    PubMed     Abstract available


  151. SCHUMACHER CM, Tao X, Chandran A, Fields E, et al
    Reaching those most at risk for HIV acquisition: Evaluating Racial/Ethnic disparities in the PrEP Care Continuum in Baltimore City, Maryland.
    J Acquir Immune Defic Syndr. 2021 Apr 19. pii: 00126334-900000000-95894.
    PubMed     Abstract available


  152. HANS L, von Allmen N, Edelmann A, Hofmann J, et al
    Early diagnosis of HIV-1 and HIV-2 using cobas HIV-1/HIV-2 Qualitative, a novel qualitative nucleic acid amplification test for plasma, serum and dried blood spot specimens.
    J Acquir Immune Defic Syndr. 2021 Apr 19. pii: 00126334-900000000-95893.
    PubMed     Abstract available


  153. CRANE HM, Nance RM, Avoundjian T, Harding BN, et al
    Types of Stroke Among People Living With HIV in the United States.
    J Acquir Immune Defic Syndr. 2021;86:568-578.
    PubMed     Abstract available


  154. MEHROTRA ML, Westmoreland DA, Patel VV, Hojilla JC, et al
    Breaking Inertia: Movement Along the PrEP Cascade in a Longitudinal US National Cohort of Sexual Minority Individuals at Risk for HIV.
    J Acquir Immune Defic Syndr. 2021;86:e118-e125.
    PubMed     Abstract available


  155. VALENTE PK, Biello KB, Edeza A, Klasko-Foster L, et al
    Psychosocial Problems and Vulnerability to HIV in a Multi-City Prospective Cohort of Young Transgender Women in the United States: A Structural Equation Modeling Study.
    J Acquir Immune Defic Syndr. 2021;86:544-551.
    PubMed     Abstract available


  156. CHAS J, Bauer R, Larabi IA, Peytavin G, et al
    Evaluation of Drug Abuse by Hair Analysis and Self-Reported Use Among MSM Under PrEP: Results From a French Substudy of the ANRS-IPERGAY Trial.
    J Acquir Immune Defic Syndr. 2021;86:552-561.
    PubMed     Abstract available


  157. FREEMAN EE, Semeere A, McMahon DE, Byakwaga H, et al
    Beyond T Staging in the "Treat All" Era: Severity and Heterogeneity of Kaposi's Sarcoma in East Africa.
    J Acquir Immune Defic Syndr. 2021 Apr 14. pii: 00126334-900000000-95895.
    PubMed     Abstract available


  158. SUMARI-DE BOER M, Ngowi KM, Sonda T, Pima FM, et al
    Effect of Digital Adherence Tools on adherence to antiretroviral treatment among adults living with HIV in Kilimanjaro, Tanzania: a randomized controlled trial.
    J Acquir Immune Defic Syndr. 2021 Apr 10. pii: 00126334-900000000-95898.
    PubMed     Abstract available


  159. MISHRA A, Mshweshwe-Pakela N, Kubeka G, Hansoti B, et al
    Systems analysis to increase HIV testing delivery and HIV diagnosis in primary care clinics in South Africa.
    J Acquir Immune Defic Syndr. 2021 Apr 5. pii: 00126334-900000000-95899.
    PubMed     Abstract available


  160. SINGHVI DG, Nouraie M, Kessinger C, McMahon DK, et al
    Association between Pain, Pulmonary Function, and Respiratory Symptoms in People with HIV.
    J Acquir Immune Defic Syndr. 2021 Apr 5. pii: 00126334-900000000-95897.
    PubMed     Abstract available


  161. HSIEH SM, Pan SC, Huang YS, Chang SC, et al
    Reversal of Viral Latency and Induction of Gag-Specific T-Cell Responses in HIV-1-Infected Adults Through Cyclic Treatment Interruption of Rosuvastatin: A Proof-of-Concept Study.
    J Acquir Immune Defic Syndr. 2021;86:500-508.
    PubMed     Abstract available


  162. YIGIT I, Bayramoglu Y, Weiser SD, Johnson MO, et al
    Disclosure Concerns and Viral Suppression in People Newly Initiating HIV Care: The Role of Internalized HIV Stigma.
    J Acquir Immune Defic Syndr. 2021;86:406-412.
    PubMed     Abstract available


  163. BOSSARD C, Schramm B, Wanjala S, Jain L, et al
    High prevalence of NRTI and NNRTI drug resistance among ART-experienced, hospitalized inpatients.
    J Acquir Immune Defic Syndr. 2021 Apr 1. pii: 00126334-900000000-95902.
    PubMed     Abstract available


  164. BAVINTON BR, Vaccher S, Jin F, Prestage GP, et al
    High levels of prevention-effective adherence to HIV pre-exposure prophylaxis (PrEP): An analysis of sub-study data from the EPIC-NSW trial.
    J Acquir Immune Defic Syndr. 2021 Apr 1. pii: 00126334-900000000-95901.
    PubMed     Abstract available


  165. PELUSO MJ, Dee L, Taylor J, Campbell DM, et al
    SARS-CoV-2 vaccination in the context of ongoing HIV cure-related research studies.
    J Acquir Immune Defic Syndr. 2021 Apr 1. pii: 00126334-900000000-95900.
    PubMed    


    March 2021
  166. KHOSROPOUR CM, Dombrowski JC, Barbee LA, Kerani RP, et al
    Changing Patterns of Sexual Behavior and HIV/STI among Men who Have Sex with Men in Seattle, 2002 to 2018.
    J Acquir Immune Defic Syndr. 2021 Mar 23. pii: 00126334-900000000-95906.
    PubMed     Abstract available


  167. JEWELL BL, Balzer LB, Clark TD, Charlebois ED, et al
    Predicting HIV Incidence in the SEARCH Trial: A Mathematical Modeling Study.
    J Acquir Immune Defic Syndr. 2021 Mar 23. pii: 00126334-900000000-95905.
    PubMed     Abstract available


  168. CORNELISSE VJ, Traeger MW, Wright EJ, Murphy D, et al
    Low incidence of hepatitis C among a cohort of HIV-negative gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Melbourne, Australia, and the contribution of sexual transmission.
    J Acquir Immune Defic Syndr. 2021 Mar 23. pii: 00126334-900000000-95904.
    PubMed     Abstract available


  169. OKERE NE, Lennox L, Urlings L, Ford N, et al
    Exploring sustainability in the era of differentiated HIV service delivery in Sub-Saharan Africa: A systematic review.
    J Acquir Immune Defic Syndr. 2021 Mar 23. pii: 00126334-900000000-95903.
    PubMed     Abstract available


  170. SHIAU S, Cantos A, Ramon CV, Shen Y, et al
    Epigenetic age in young African American adults with perinatally-acquired HIV.
    J Acquir Immune Defic Syndr. 2021 Mar 18. pii: 00126334-900000000-95907.
    PubMed     Abstract available


  171. HINES JZ, Sachathep K, Pals S, Davis SM, et al
    HIV incidence by male circumcision status from the population-based HIV impact assessment (PHIA) surveys-eight sub-Saharan African countries, 2015-2017.
    J Acquir Immune Defic Syndr. 2021 Mar 16. pii: 00126334-900000000-95908.
    PubMed     Abstract available


  172. CHAN PA, Nunn A, Van Den Berg JJ, Cormier K, et al
    A randomized trial of a brief behavioral intervention for PrEP uptake among men who have sex with men at increased risk for HIV infection.
    J Acquir Immune Defic Syndr. 2021 Mar 15. pii: 00126334-900000000-95909.
    PubMed     Abstract available



  173. Bacterial Vaginosis and Risk of HIV Infection in the Context of CD101 Gene Variation: Erratum.
    J Acquir Immune Defic Syndr. 2021;86:387.
    PubMed    


  174. PLUZNIK JA, Nijhawan AE, Spaulding AC
    Does Anything Work? Improving HIV Care Engagement for Individuals Transitioning out of Correctional Settings.
    J Acquir Immune Defic Syndr. 2021;86:286-287.
    PubMed    


  175. COOLEY SA, Navid J, Wisch JK, Boerwinkle A, et al
    Relationships between Viral Load, Neuroimaging and Neuropsychological Performance in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Mar 1. pii: 00126334-900000000-95915.
    PubMed     Abstract available


  176. BAKER Z, Javanbacht M, Moore J, Brosnan H, et al
    A qualitative study on the acceptability of and adherence to a vaginal ring for HIV prophylaxis among adolescent girls.
    J Acquir Immune Defic Syndr. 2021 Mar 1. pii: 00126334-900000000-95914.
    PubMed     Abstract available


  177. SILHOL R, Geidelberg L, Mitchell KM, Mishra S, et al
    Assessing the potential impact of disruptions due to COVID-19 on HIV among key and lower-risk populations in the largest cities of Cameroon and Benin.
    J Acquir Immune Defic Syndr. 2021 Mar 1. pii: 00126334-900000000-95920.
    PubMed     Abstract available


  178. LEVY ME, Agopian A, Magnus M, Rawls A, et al
    Is Long-Acting Injectable Cabotegravir Likely to Expand PrEP Coverage Among MSM in the District of Columbia?
    J Acquir Immune Defic Syndr. 2021;86:e80-e82.
    PubMed    


    February 2021
  179. EDELMAN EJ, Gan G, Dziura J, Esserman D, et al
    Readiness to provide medications for opioid, alcohol and tobacco use disorder in HIV clinics: A multi-site mixed-methods formative evaluation.
    J Acquir Immune Defic Syndr. 2021 Feb 26. pii: 00126334-900000000-95919.
    PubMed     Abstract available


  180. SOMERVILLE K, Jenkins CA, Carlucci JG, Person AK, et al
    Outcomes After Second-Line Antiretroviral Therapy in Children Living with HIV in Latin America.
    J Acquir Immune Defic Syndr. 2021 Feb 26. pii: 00126334-900000000-95918.
    PubMed     Abstract available


  181. BATHER JR, Williams PL, Broadwell C, Smith R, et al
    Racial/Ethnic Disparities in Longitudinal Emotional-Behavioral Functioning Among Youth Born to Women Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 26. pii: 00126334-900000000-95917.
    PubMed     Abstract available


  182. JANULIS P, Goodreau SM, Birkett M, Phillips G 2nd, et al
    Temporal variation in one-time partnership rates among young men who have sex with men and transgender women.
    J Acquir Immune Defic Syndr. 2021 Feb 26. pii: 00126334-900000000-95916.
    PubMed     Abstract available


  183. ERLY SJ, Naismith K, Kerani R, Buskin SE, et al
    Predictive Value of Time-Space Clusters for HIV Transmission in Washington State, 2017-2019.
    J Acquir Immune Defic Syndr. 2021 Feb 24. pii: 00126334-900000000-95923.
    PubMed     Abstract available


  184. BHUSHAN NL, Stoner MCD, Twine R, Kahn K, et al
    Community Space, Community Groups, and Incident HIV Infection Among Adolescent Girls and Young Women in Rural South Africa: A Longitudinal Analysis of HIV Prevention Trials Network 068 Data.
    J Acquir Immune Defic Syndr. 2021 Feb 24. pii: 00126334-900000000-95922.
    PubMed     Abstract available


  185. TAMARGO JA, Martin HR, Diaz-Martinez J, Trepka MJ, et al
    COVID-19 Testing and The Impact of The Pandemic on The Miami Adult Studies on HIV (MASH) Cohort.
    J Acquir Immune Defic Syndr. 2021 Feb 24. pii: 00126334-900000000-95921.
    PubMed     Abstract available


  186. BRUXVOORT KJ, Schumacher CM, Towner W, Jones J, et al
    Referral linkage to pre-exposure prophylaxis (PrEP) care and persistence on PrEP in an integrated healthcare system.
    J Acquir Immune Defic Syndr. 2021 Feb 23. pii: 00126334-900000000-95928.
    PubMed     Abstract available


  187. NEARY J, Wagner AD, Omondi V, Otieno V, et al
    Male caregiver barriers to HIV index-case testing of untested children.
    J Acquir Immune Defic Syndr. 2021 Feb 23. pii: 00126334-900000000-95927.
    PubMed     Abstract available


  188. TAGGART T, Mayer KH, Vermund SH, Huang S, et al
    Interaction of religion/spirituality with internalized HIV stigma, depression, alcohol use, and sexual risk among Black men who have sex with men: The six city HPTN 061 study.
    J Acquir Immune Defic Syndr. 2021 Feb 23. pii: 00126334-900000000-95926.
    PubMed     Abstract available


  189. DRIVSHOLM N, Knudsen AD, Faurholt-Jepsen M, Midttun O, et al
    Alterations in the kynurenine pathway of tryptophan metabolism are associated with depression in people living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 23. pii: 00126334-900000000-95925.
    PubMed     Abstract available


  190. MONTGOMERY ET, Browne E, Atujuna M, Boeri M, et al
    Long-acting injection and implant preferences and trade-offs for HIV prevention among South African male youth.
    J Acquir Immune Defic Syndr. 2021 Feb 22. pii: 00126334-900000000-95924.
    PubMed     Abstract available


  191. KUMAR P, Johnson M, Molina JM, Rizzardini G, et al
    Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT Trial.
    J Acquir Immune Defic Syndr. 2021 Feb 17. pii: 00126334-900000000-95929.
    PubMed     Abstract available


  192. EJIMA K, Koizumi Y, Yamamoto N, Rosenberg M, et al
    HIV testing by public health centers and municipalities and new HIV cases during the COVID-19 pandemic in Japan.
    J Acquir Immune Defic Syndr. 2021 Feb 17. pii: 00126334-900000000-95932.
    PubMed     Abstract available


  193. KELLY SG, Wu K, Tassiopoulos K, Erlandson KM, et al
    Incorporating frailty into the Pooled Cohort Equations to predict cardiovascular disease among persons with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 17. pii: 00126334-900000000-95931.
    PubMed     Abstract available


  194. CINDI Z, Maartens G, Bradford Y, Venter F, et al
    Genetic Associations with Weight Gain among South Africans who Initiated Dolutegravir- and Tenofovir-containing Regimens.
    J Acquir Immune Defic Syndr. 2021 Feb 17. pii: 00126334-900000000-95930.
    PubMed     Abstract available


  195. NOWAK RG, Liska TA, Bentzen SM, Kim E, et al
    Herpes Simplex Virus Type-2 shedding and genital ulcers during early HIV in Zimbabwean women.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95936.
    PubMed     Abstract available


  196. TRUONG HM, Fatch R, McFarland W, Raymond HF, et al
    HIV Prevention Responsibility Beliefs Among Men Who Have Sex with Men in the PrEP Era.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95935.
    PubMed     Abstract available


  197. VAN WYK J, Ait-Khaled M, Santos J, Scholten S, et al
    Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95934.
    PubMed     Abstract available


  198. KOHN JN, Loop MS, Kim-Chang JJ, Garvie PA, et al
    Trajectories of depressive symptoms, neurocognitive function and viral suppression with antiretroviral therapy among youth with HIV over 36 months.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95933.
    PubMed     Abstract available


  199. NIJHAWAN AE, Mathews WC, Raifman J, Fleming J, et al
    Hospitalization rates among persons with HIV who gained Medicaid or private insurance after the Affordable Care Act in 2014.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95945.
    PubMed     Abstract available


  200. MGODI NM, Takuva S, Edupuganti S, Karuna S, et al
    A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection in women in sub-Saharan Africa: baseline findings.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95944.
    PubMed     Abstract available


  201. PALEFSKY JM, Poongulali S, Lensing S, Lee J, et al
    AIDS Malignancy Consortium 054: Safety and Immunogenicity of the Quadrivalent vaccine in Indian Women Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95943.
    PubMed     Abstract available


  202. PRICE JT, Vwalika B, Edwards JK, Cole SR, et al
    Maternal HIV infection and spontaneous versus provider-initiated preterm birth in an urban Zambian cohort.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95942.
    PubMed     Abstract available


  203. HUANG SH, Huang WC, Lin SW, Chuang YC, et al
    Impact of efavirenz mid-dose plasma concentration on long-term weight change among virologically suppressed people living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95941.
    PubMed     Abstract available


  204. PELCHEN-MATTHEWS A, Borges AH, Reekie J, Rasmussen LD, et al
    Prevalence and Outcomes for Heavily Treatment-Experienced (HTE) Individuals Living with Human Immunodeficiency Virus in a European Cohort.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95940.
    PubMed     Abstract available


  205. EDUPUGANTI S, Mgodi N, Karuna ST, Andrew P, et al
    Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95939.
    PubMed     Abstract available


  206. CACHAY ER, Torriani FJ, Hill L, Rajagopal A, et al
    HCV knowledge and Recent Diagnosis Affect HCV Treatment Willingness in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95938.
    PubMed     Abstract available


  207. VERA JH, Eftychiou N, Schuerer M, Rullmann M, et al
    CLINICAL UTILITY OF beta-AMYLOID PET IMAGING IN PEOPLE LIVING WITH HIV WITH COGNITIVE SYMPTOMS.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95937.
    PubMed     Abstract available


  208. FARAHANI M, Radin E, Saito S, Sachathep K, et al
    Population Viral Load, Viremia and Recent HIV-1 Infections: Findings from Population-based HIV Impact Assessments (PHIAs) in Zimbabwe, Malawi, and Zambia.
    J Acquir Immune Defic Syndr. 2021 Feb 5. pii: 00126334-900000000-95947.
    PubMed     Abstract available


  209. SHARMA A, Hoover DR, Shi Q, Gustafson DR, et al
    High Frequency of Recurrent Falls among Pre-frail and Frail Women with and without HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 2. pii: 00126334-900000000-95950.
    PubMed     Abstract available


  210. PAGKAS-BATHER J, Khosropour CM, Golden MR, Thibault C, et al
    Population-level Effectiveness of HIV pre-exposure prophylaxis among MSM and Transgender Persons with Bacterial Sexually Transmitted Infections.
    J Acquir Immune Defic Syndr. 2021 Feb 2. pii: 00126334-900000000-95949.
    PubMed     Abstract available


  211. PATEL VV, Felsen UR, Fisher M, Fazzari MJ, et al
    Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19.
    J Acquir Immune Defic Syndr. 2021;86:224-230.
    PubMed     Abstract available


  212. MUCCINI C, Crowell TA, Pinyakorn S, Kroon E, et al
    Brief Report: Syphilis Incidence and Effect on Viral Load, CD4, and CD4/CD8 Ratio in a Thai Cohort of Predominantly Men Who Have Sex With Men Living With HIV.
    J Acquir Immune Defic Syndr. 2021;86:219-223.
    PubMed     Abstract available


  213. CRANE HM, Nance RM, Whitney BM, Heckbert SR, et al
    Brief Report: Differences in Types of Myocardial Infarctions Among People Aging With HIV.
    J Acquir Immune Defic Syndr. 2021;86:208-212.
    PubMed     Abstract available


  214. CHOW EPF, Hocking JS, Ong JJ, Phillips TR, et al
    Brief Report: Changes in PrEP Use, Sexual Practice, and Use of Face Mask During Sex Among MSM During the Second Wave of COVID-19 in Melbourne, Australia.
    J Acquir Immune Defic Syndr. 2021;86:153-156.
    PubMed     Abstract available


    January 2021
  215. SABERI P, Ming K, Hojilla JC, Scott HM, et al
    HIV pre-exposure prophylaxis in the time of COVID-19: How a robust and responsive HIV PrEP intervention can avert loss of HIV prevention coverage during a global pandemic.
    J Acquir Immune Defic Syndr. 2021 Jan 29. pii: 00126334-900000000-95952.
    PubMed    


  216. WAIRIMU F, Ward NC, Liu Y, Dwivedi G, et al
    Cardiac transplantation in HIV positive patients: a narrative review.
    J Acquir Immune Defic Syndr. 2021 Jan 29. pii: 00126334-900000000-95951.
    PubMed     Abstract available


  217. TIEN-HUAN L, Ismael FC, Suzue S, Rommel B, et al
    Evaluating Nonresponse Weighting Adjustment for the Population-Based HIV Impact Assessments Surveys: On Incorporating Survey Outcomes.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95955.
    PubMed     Abstract available


  218. JOHNSON KA, Chen MJ, Kohn R, Sachdev D, et al
    Acute HIV at the time of initiation of Pre or Post Exposure Prophylaxis: Impact on drug-resistance and clinical outcomes.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95954.
    PubMed     Abstract available


  219. PAMPATI S, Emrick K, Siegler AJ, Jones J, et al
    Changes in sexual behavior, PrEP adherence, and access to sexual health services due to the COVID-19 pandemic among a cohort of PrEP-using MSM in the South.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95953.
    PubMed     Abstract available


  220. VAN DER HEIJDEN WA, Wan J, Van de Wijer L, Jaeger M, et al
    Plasmatic coagulation capacity correlates with inflammation and abacavir-use during chronic HIV-infection.
    J Acquir Immune Defic Syndr. 2021 Jan 26. pii: 00126334-900000000-95956.
    PubMed     Abstract available


  221. GOODRICH S, Siika A, Mwangi A, Nyambura M, et al
    Development, assessment and outcomes of a community-based model of anti-retroviral care in western Kenya through a cluster-randomized control trial.
    J Acquir Immune Defic Syndr. 2021 Jan 21. pii: 00126334-900000000-95957.
    PubMed     Abstract available


  222. ONGOLLY FK, Dolla A, Ngure K, Irungu EM, et al
    "I just decided to stop: " Understanding PrEP discontinuation among individuals initiating PrEP in HIV care centers in Kenya.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95963.
    PubMed     Abstract available


  223. COBURN SB, Shiels M, Silverberg M, Horberg M, et al
    Secular Trends in Breast Cancer Risk among Women with HIV Initiating ART in North America.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95962.
    PubMed     Abstract available


  224. ZHANG L, Abohashem S, Osborne MT, Naddaf N, et al
    Lower Socioeconomic Status Associates with Greater Systemic and Arterial Inflammation in HIV.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95961.
    PubMed     Abstract available


  225. CHEN Y, Gao Y, Zhou Y, Li X, et al
    Human Immunodeficiency Virus Infection and Incident Heart Failure: A Meta-analysis of Prospective Studies.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95958.
    PubMed     Abstract available


  226. BUSZA J, Hensen B, Birdthistle I, Chabata ST, et al
    What's in a name? A mixed method study on how young women who sell sex characterise male partners and their use of condoms.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95964.
    PubMed     Abstract available


  227. CRABLE EL, Blue TR, McKenzie M, Rich JD, et al
    Effect of case management on HIV outcomes for community corrections population: Results of an 18-month randomized controlled trial.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95960.
    PubMed     Abstract available


  228. MUCCINI C, Galli L, Poli A, Chiurlo M, et al
    Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95959.
    PubMed    


  229. RANA MN, Kim CH, Sullivan CE, Longenecker CT, et al
    Performance of Methods to Estimate Low-Density Lipoprotein Cholesterol in Women with and without HIV infection.
    J Acquir Immune Defic Syndr. 2021 Jan 18. pii: 00126334-900000000-95966.
    PubMed     Abstract available


  230. BIEN-GUND CH, Ho JI, Bair EF, Marcus N, et al
    Financial incentives and real-time adherence monitoring to promote daily adherence to HIV treatment and viral suppression among people living with HIV: a pilot study.
    J Acquir Immune Defic Syndr. 2021 Jan 15. pii: 00126334-900000000-95965.
    PubMed     Abstract available


  231. DIRAJLAL-FARGO S, Williams PL, Broadwell C, McFARLAND EJ, et al
    Youth living with perinatally-acquired HIV have lower physical activity levels as they age compared to HIV-exposed uninfected youth.
    J Acquir Immune Defic Syndr. 2021 Jan 13. pii: 00126334-900000000-95968.
    PubMed     Abstract available


  232. RAO A, Rucinski K, Jarrett B, Ackerman B, et al
    Perceived interruptions to HIV prevention and treatment services associated with COVID-19 for gay, bisexual, and other men who have sex with men in 20 countries.
    J Acquir Immune Defic Syndr. 2021 Jan 13. pii: 00126334-900000000-95967.
    PubMed     Abstract available


  233. GATHE JC, Hardwicke RL, Garcia F, Weinheimer S, et al
    Efficacy, pharmacokinetics and safety over 48 weeks with ibalizumab-based therapy in treatment-experienced adults infected with HIV-1: A Phase 2a study.
    J Acquir Immune Defic Syndr. 2021;Publish Ahead of Print.
    PubMed     Abstract available


  234. MEGGI B, Bollinger T, Zitha A, Mudenyanga C, et al
    Performance of a True Point-of-Care Assay for HIV-1/2 Viral Load Measurement at Antenatal and Postpartum Services.
    J Acquir Immune Defic Syndr. 2021;Publish Ahead of Print.
    PubMed     Abstract available


  235. HENRY RT, Jiamsakul A, Law M, Losso M, et al
    Factors Associated With And Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants.
    J Acquir Immune Defic Syndr. 2021;Publish Ahead of Print.
    PubMed     Abstract available


  236. SPRING S, O'Bryan J, McMahon J, Woolley I, et al
    Acceptability of Injectable Antiretroviral Therapy in Australian Travelers With HIV.
    J Acquir Immune Defic Syndr. 2021;86:e13-e15.
    PubMed    


  237. FABBIANI M, Borghetti A, Squillace N, Colafigli M, et al
    Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy.
    J Acquir Immune Defic Syndr. 2021;86:119-127.
    PubMed     Abstract available


  238. DUNN D, Price H, Vudriko T, Kityo C, et al
    New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings.
    J Acquir Immune Defic Syndr. 2021;86:98-103.
    PubMed     Abstract available


  239. ELLSWORTH GB, Burke LA, Wells MT, Mishra S, et al
    Randomized Pilot Study of an Advanced Smart-Pill Bottle as an Adherence Intervention in Patients With HIV on Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2021;86:73-80.
    PubMed     Abstract available


  240. ONONO M, Odwar T, Wahome S, Helova A, et al
    Behavioral Interventions can Mitigate Adverse Pregnancy Outcomes Among Women Conceiving on ART and Those Initiated on ART During Pregnancy: Findings From the MOTIVATE Trial in Southwestern Kenya.
    J Acquir Immune Defic Syndr. 2021;86:46-55.
    PubMed     Abstract available


  241. SCHNEIDER JA, Young L, Ramachandran A, Michaels S, et al
    A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago.
    J Acquir Immune Defic Syndr. 2021;86:31-37.
    PubMed     Abstract available


  242. PAHWA S, Deeks S, Zou S, Tomitch N, et al
    NIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future Research.
    J Acquir Immune Defic Syndr. 2021;86:11-18.
    PubMed     Abstract available


    December 2020
  243. OLALI AZ, Sharma A, Shi Q, Hoover DR, et al
    Change in circulating undercarboxylated osteocalcin (ucOCN) is associated with fat accumulation in HIV-seropositive women.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  244. MCQUILLAN GM, Kruszon-Moran D, Gu Q, Masciotra S, et al
    Prevalence and trends in HIV infection and testing among adults in the United States: The National Health and Nutrition Examination Surveys, 1999-2018.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  245. MOSKOWITZ DA, Moran KO, Matson M, Alvarado-Avila A, et al
    The PrEP cascade in a national cohort of adolescent men who have sex with men.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  246. FELNER JK, Mittal ML, Hoenigl M, Amico KR, et al
    Constructions of HIV Risk Among a Diverse Sample of HIV-Negative Young Men who have Sex with Men who are Repeat Testers.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  247. MOHAREB AM, Patel AV, Laeyendecker OB, Toerper MF, et al
    The HIV screening cascade: current Emergency Department-based screening strategies leave many patients with HIV undiagnosed.
    J Acquir Immune Defic Syndr. 2020 Dec 28. doi: 10.1097/QAI.0000000000002609.
    PubMed    


  248. MULATU MS, Wang G, Song W, Keatley J, et al
    HIV Testing, Diagnosis of HIV Infection, Linkage to Medical Care, and Interview for Partner Services among Transgender Persons - United States, 2012-2017.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  249. MOSHIRI N, Smith DM, Mirarab S
    HIV Care Prioritization using Phylogenetic Branch Length.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  250. O'HALLORAN JA, Wang K, Spence AB, Williams DW, et al
    Integrase Strand Transfer Inhibitor Start or Switch Impacts Learning in Women with HIV.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  251. LEDERMAN MM
    AIDS in the Heartland- Hemophilia was the Harbinger of Things to Come.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  252. BLAIR CS, Lake JE, Passaro RC, Chavez-Gomez S, et al
    HIV-1 Seroconversion is Not Associated with Prolonged Rectal Mucosal Inflammation.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  253. PETOUMENOS K, Kuwanda L, Ryom L, Mocroft A, et al
    Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study\.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  254. WEISER JK, Tie Y, Beer L, Fanfair RN, et al
    Racial/ethnic and Income Disparities in the Prevalence of Comorbidities that Are Associated With Risk for Severe COVID-19 Among Adults Receiving HIV Care, United States, 2014-2019.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  255. KATZ IT, Musinguzi N, Bell K, Cross A, et al
    The Impact of Disease Stage on Early Gaps in ART in the "Treatment for All" Era - A Multisite Cohort Study.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  256. SAMRI A, Chalouni M, Blanco J, Behrens G, et al
    Influence of the ARV regimen on the early changes in plasma HIV RNA and immune activation at initiation of antiretroviral therapy in naive HIV-1-infected patients.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed    


  257. TOLENTINO A, Amaral S, Souza LS, Zeballos D, et al
    Frequency of falls and associated risk factors in people living with HIV: a systematic review with meta-analysis and meta-regression.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  258. STEK C, Buyze J, Menten J, Schutz C, et al
    Diagnostic accuracy of the INSHI consensus case definition for the diagnosis of paradoxical tuberculosis-IRIS.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  259. CHOW EPF, Ong JJ, Denham I, Fairley CK, et al
    HIV testing and diagnoses during the COVID-19 pandemic in Melbourne, Australia.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    PubMed    


  260. MALLARINO-HAEGER C, Abebe KZ, Jackson EK, Zyhowski A, et al
    Brief Report: Dipyridamole Decreases Gut Mucosal Regulatory T-Cell Frequencies Among People With HIV on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2020;85:665-669.
    PubMed     Abstract available


  261. GINGRICH D, Deitchman AN, Kantor A, Huang L, et al
    Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV.
    J Acquir Immune Defic Syndr. 2020;85:651-658.
    PubMed     Abstract available


  262. HSIEH YL, Jahn A, Menzies NA, Yaesoubi R, et al
    Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi.
    J Acquir Immune Defic Syndr. 2020;85:643-650.
    PubMed     Abstract available


  263. TORGERSEN J, Kallan MJ, Carbonari DM, Park LS, et al
    Brief Report: Accuracy of FIB-4 for Cirrhosis in People Living With HIV and Hepatocellular Carcinoma.
    J Acquir Immune Defic Syndr. 2020;85:530-534.
    PubMed     Abstract available


  264. LINNEMAYR S, Barreras JL, Izenberg M, Brooks RA, et al
    Longitudinal Assessment of Changes in Mental and Sexual Health Outcomes Due to COVID-19 Among Latinx SMM and TGW.
    J Acquir Immune Defic Syndr. 2020;85:e90-e92.
    PubMed    


  265. PEREZ-VALERO I, Llibre JM, Castagna A, Pulido F, et al
    Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation.
    J Acquir Immune Defic Syndr. 2020 Dec 10. doi: 10.1097/QAI.0000000000002595.
    PubMed     Abstract available


  266. ELLIS RJ, Iudicello J, Sun-Suslow N, Grelotti D, et al
    Social isolation is linked to inflammation in aging people with HIV and uninfected individuals.
    J Acquir Immune Defic Syndr. 2020 Dec 8. doi: 10.1097/QAI.0000000000002596.
    PubMed     Abstract available


  267. ABRAMS EJ, Mofenson LM, Pozniak A, Lockman S, et al
    Enhanced and timely investigation of ARVs for use in pregnant women.
    J Acquir Immune Defic Syndr. 2020 Dec 8. doi: 10.1097/QAI.0000000000002597.
    PubMed     Abstract available


  268. NAIDOO K, Mansoor LE, Katz AW, Garcia M, et al
    Qualitative perceptions of dapivirine vaginal ring adherence and drug level feedback following an open-label extension trial.
    J Acquir Immune Defic Syndr. 2020 Dec 3. doi: 10.1097/QAI.0000000000002590.
    PubMed     Abstract available


  269. SINHA A, Mystakelis H, Rivera AS, Manion M, et al
    Association of Low CD4/CD8 Ratio With Adverse Cardiac Mechanics in Lymphopenic HIV-Infected Adults.
    J Acquir Immune Defic Syndr. 2020;85:e73-e76.
    PubMed    


  270. MANSERGH G, Stephenson R, Hirshfield S, Sullivan P, et al
    Understanding HIV Sexual Protection and Its Association With Substance Use During Sex Among MSM in an Era of Multiple Primary Prevention Products.
    J Acquir Immune Defic Syndr. 2020;85:e67.
    PubMed    


  271. POTEAT TC, Reisner SL, Miller M, Wirtz AL, et al
    Vulnerability to COVID-19-related Harms Among Transgender Women With and Without HIV Infection in the Eastern and Southern U.S.
    J Acquir Immune Defic Syndr. 2020;85:e67-e69.
    PubMed     Abstract available


  272. THORBALL CW, Borghesi A, Bachmann N, Von Siebenthal C, et al
    Host Genomics of the HIV-1 Reservoir Size and Its Decay Rate During Suppressive Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2020;85:517-524.
    PubMed     Abstract available


  273. LUCAS GM, Atta MG, Zook K, Vaidya D, et al
    Cross-Sectional and Longitudinal Performance of Creatinine- and Cystatin C-Based Estimating Equations Relative to Exogenously Measured Glomerular Filtration Rate in HIV-Positive and HIV-Negative Persons.
    J Acquir Immune Defic Syndr. 2020;85:e58-e66.
    PubMed     Abstract available


  274. RODRIGUEZ VJ, Zegarac M, La Barrie DL, Parrish MS, et al
    Validation of the Bayley Infant Neurodevelopmental Screener Among HIV-Exposed Infants in Rural South Africa.
    J Acquir Immune Defic Syndr. 2020;85:507-516.
    PubMed     Abstract available


  275. RIZZARDINI G, Overton ET, Orkin C, Swindells S, et al
    Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials.
    J Acquir Immune Defic Syndr. 2020;85:498-506.
    PubMed     Abstract available


  276. HAN WM, Bijker R, Chandrasekaran E, Pujari S, et al
    Validation of the D: A: D Chronic Kidney Disease Risk Score Model Among People Living With HIV in the Asia-Pacific.
    J Acquir Immune Defic Syndr. 2020;85:489-497.
    PubMed     Abstract available


  277. MANN SC, Morrow M, Coyle RP, Coleman SS, et al
    Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus.
    J Acquir Immune Defic Syndr. 2020;85:483-488.
    PubMed     Abstract available


  278. BALLIVIAN J, Alcaide ML, Cecchini D, Jones DL, et al
    Impact of COVID-19-Related Stress and Lockdown on Mental Health Among People Living With HIV in Argentina.
    J Acquir Immune Defic Syndr. 2020;85:475-482.
    PubMed     Abstract available


  279. BK K, Tiwari S, Chhapola V, Debnath E, et al
    Brief Report: Subclinical Kidney Dysfunction in HIV-Infected Children: A Cross-Sectional Study.
    J Acquir Immune Defic Syndr. 2020;85:470-474.
    PubMed     Abstract available


  280. MCCLEAN M, Buzkova P, Budoff M, Estrella M, et al
    Brief Report: Cystatin C-Based Estimation of Glomerular Filtration Rate and Association With Atherosclerosis Imaging Markers in People Living With HIV.
    J Acquir Immune Defic Syndr. 2020;85:466-469.
    PubMed     Abstract available


  281. MILLER L, Morar N, Kapiga S, Ramjee G, et al
    Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    J Acquir Immune Defic Syndr. 2020;85:458-465.
    PubMed     Abstract available


  282. HEBEL S, Kahn-Woods E, Malone-Thomas S, McNeese M, et al
    Brief Report: Discrepancies Between Self-Reported Adherence and a Biomarker of Adherence in Real-World Settings.
    J Acquir Immune Defic Syndr. 2020;85:454-457.
    PubMed     Abstract available


  283. BOYD AT, Odume B, Sidibe K, Onotu D, et al
    Brief Report: Programmatic Scale-up of Tuberculosis Preventive Treatment Among People Living With HIV Through Targeted Technical Assistance to High-Volume Antiretroviral Treatment Sites-Nigeria, 2018-2019.
    J Acquir Immune Defic Syndr. 2020;85:450-453.
    PubMed     Abstract available


  284. CONTE M, Eshun-Wilson I, Geng E, Imbert E, et al
    Brief Report: Understanding Preferences for HIV Care Among Patients Experiencing Homelessness or Unstable Housing: A Discrete Choice Experiment.
    J Acquir Immune Defic Syndr. 2020;85:444-449.
    PubMed     Abstract available


  285. DEAN LT, Nonyane BAS, Ugoji C, Visvanathan K, et al
    Economic Burden Among Gay, Bisexual, and Other Men Who Have Sex With Men Living With HIV or Living Without HIV in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2020;85:436-443.
    PubMed     Abstract available


  286. CHAPIN-BARDALES J, Johnson Jones ML, Kirkcaldy RD, Bernstein KT, et al
    Pre-exposure Prophylaxis Use and Detected Sexually Transmitted Infections Among Men Who Have Sex With Men in the United States-National HIV Behavioral Surveillance, 5 US Cities, 2017.
    J Acquir Immune Defic Syndr. 2020;85:430-435.
    PubMed     Abstract available


  287. MOORE JR, Donnell DJ, Boily MC, Mitchell KM, et al
    Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression.
    J Acquir Immune Defic Syndr. 2020;85:423-429.
    PubMed     Abstract available


  288. JEAN LOUIS F, Domercant JW, Ignacio C, Gianella S, et al
    High Prevalence of HIV-1 Drug Resistance and Dynamics of Transmission Among High-Risk Populations in Port-au-Prince, Haiti.
    J Acquir Immune Defic Syndr. 2020;85:416-422.
    PubMed     Abstract available


  289. XIA Y, Greenwald ZR, Milwid RM, Trottier C, et al
    Pre-exposure Prophylaxis Uptake Among Men Who Have Sex With Men Who Used nPEP: A Longitudinal Analysis of Attendees at a Large Sexual Health Clinic in Montreal (Canada).
    J Acquir Immune Defic Syndr. 2020;85:408-415.
    PubMed     Abstract available


  290. DE ANDA S, Njoroge A, Njuguna I, Dunbar MD, et al
    Predictors of First-Time and Repeat HIV Testing Among HIV-Positive Individuals in Kenya.
    J Acquir Immune Defic Syndr. 2020;85:399-407.
    PubMed     Abstract available


  291. MOORE M, Boily MC, Mitchell KM, Donnell DD, et al
    Identifying Regions of Greatest Need for Ending the HIV Epidemic: A Plan for America.
    J Acquir Immune Defic Syndr. 2020;85:395-398.
    PubMed     Abstract available


  292. BRUMMEL SS, Taha TE, Angelidou KN, Saidi F, et al
    Impact of Antiretroviral Therapy on Maternal Health after Cessation of Breastfeeding.
    J Acquir Immune Defic Syndr. 2020 Dec 1. doi: 10.1097/QAI.0000000000002586.
    PubMed     Abstract available


  293. LEFEBVRE M, Walencik A, Allavena C, Billaud E, et al
    Rate of DRESS Syndrome With Raltegravir and Role of the HLA-B*53: 01 Allele.
    J Acquir Immune Defic Syndr. 2020;85:e77-e80.
    PubMed    


    November 2020
  294. HUANG YS, Cheng CY, Liou BH, Lu PL, et al
    Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide as maintenance treatment in HIV/HBV-coinfected patients.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002589.
    PubMed     Abstract available


  295. MIN HAN W, Ueaphongsukkit T, Chattranukulchai P, Siwamogsatham S, et al
    Incident liver cirrhosis, associated factors and cardiovascular disease risks among people living with HIV: a longitudinal study.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002585.
    PubMed     Abstract available


  296. MAZAHERI-TEHRANI E, Mohraz M, Nasi M, Chester J, et al
    NLRP3 and IL-1beta gene expression is elevated in monocytes from HIV treated patients with neurocognitive disorders.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002588.
    PubMed     Abstract available


  297. PINTYE J, O'Malley G, Kinuthia J, Abuna F, et al
    Influences on early discontinuation and persistence of daily oral PrEP use among Kenyan adolescent girls and young women: a qualitative evaluation from a PrEP implementation program.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002587.
    PubMed     Abstract available


  298. CELERINO DA SILVA R, Segat L, Kuhn L, Bogo Chies JA, et al
    Association of single nucleotide polymorphisms in HLA-C and ZNRD1 genes with HIV-1 mother to child transmission in Zambia population.
    J Acquir Immune Defic Syndr. 2020 Nov 23. doi: 10.1097/QAI.0000000000002584.
    PubMed     Abstract available


  299. UNG MJ, Fairley CK, Martin SJ, Ong JJ, et al
    Pre-exposure Prophylaxis for HIV - an opportunity for the global control of sexually transmitted infections.
    J Acquir Immune Defic Syndr. 2020 Nov 23. doi: 10.1097/QAI.0000000000002582.
    PubMed    


  300. PATHMANATHAN I, Nelson R, de Louvado A, Thompson R, et al
    High Coverage of Antiretroviral Treatment with Annual Home-Based HIV Testing, Follow-up Linkage Services, and Implementation of Test and Start: Findings from the Chokwe Health Demographic Surveillance System, Mozambique, 2014-2019.
    J Acquir Immune Defic Syndr. 2020 Nov 21. doi: 10.1097/QAI.0000000000002583.
    PubMed     Abstract available


  301. SILHOL R, Baral S, Bowring AL, Mukandavire C, et al
    Quantifying the evolving contribution of HIV interventions and key populations to the HIV epidemic in Yaounde, Cameroon.
    J Acquir Immune Defic Syndr. 2020 Nov 20. doi: 10.1097/QAI.0000000000002580.
    PubMed     Abstract available


  302. HAMILL MM, Hu F, Kokogho A, Shoyemi E, et al
    Factors Associated with Condom Failure in a Longitudinal Cohort of Men who have Sex with Men and Transgender Women in Abuja and Lagos, Nigeria.
    J Acquir Immune Defic Syndr. 2020 Nov 20. doi: 10.1097/QAI.0000000000002559.
    PubMed     Abstract available


  303. OLIVEIRA VH, Borsari AL, CArdenas JDG, Alves Junior CM, et al
    Low Agreement Between Initial and Revised European Consensus on Definition and Diagnosis of Sarcopenia Applied to People Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Nov 18. doi: 10.1097/QAI.0000000000002576.
    PubMed     Abstract available


  304. VAN BILSEN WPH, Zimmermann HML, Boyd A, Coyer L, et al
    Sexual behavior and its determinants during COVID-19 restrictions among men who have sex with men in Amsterdam.
    J Acquir Immune Defic Syndr. 2020 Nov 18. doi: 10.1097/QAI.0000000000002581.
    PubMed     Abstract available


  305. SEKIZIYIVU AB, Bancroft E, Rodriguez EM, Sendagala S, et al
    Task shifting for initiation and monitoring of antiretroviral therapy for HIV-infected adults in Uganda: The SHARE Trial.
    J Acquir Immune Defic Syndr. 2020 Nov 17. doi: 10.1097/QAI.0000000000002567.
    PubMed     Abstract available


  306. MACGIBBON J, Lea T, Ellard J, Murphy D, et al
    Access to subsidised healthcare affects HIV pre-exposure prophylaxis (PrEP) uptake among gay and bisexual men in Australia: results of national surveys 2013-19.
    J Acquir Immune Defic Syndr. 2020 Nov 16. doi: 10.1097/QAI.0000000000002572.
    PubMed     Abstract available


  307. ABDO M, Langan SJ, MaWhinney S, Sun J, et al
    The Effect of Statin Therapy on Age-Associated Changes in Physical Function Among Men With and Without HIV in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2020 Nov 16. doi: 10.1097/QAI.0000000000002579.
    PubMed     Abstract available


  308. BOGART LM, Ojikutu BO, Tyagi K, Klein DJ, et al
    COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002570.
    PubMed     Abstract available


  309. MULATO A, Acosta R, Chang S, Martin R, et al
    Simulating HIV Breakthrough and Resistance Development During Variable Adherence to Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002562.
    PubMed     Abstract available


  310. SCHNITTMAN SR, Zepf R, Cocohoba J, Sears D, et al
    Heplisav-B Seroprotection in People with HIV: A Single-Center Experience.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002573.
    PubMed     Abstract available


  311. ATKINS K, Rucinski K, Mudavanhu M, Holmes L, et al
    Sexual Relationship Types, Partner HIV Self-Testing, and Pre-Exposure Prophylaxis Among South African Adolescent Girls and Young Women: A Latent Class Analysis.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002569.
    PubMed     Abstract available


  312. GOSWAMI S, Hu X, Chen Q, Qiu J, et al
    Profiles of MicroRNAs in Interleukin-27-Induced HIV-Resistant T cells: Identification of a Novel Anti-Viral MicroRNA.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002565.
    PubMed     Abstract available


  313. CASALE M, Cluver L, Boyes M, Toska E, et al
    Bullying and ART non-adherence among South African adolescents living with HIV: effects, risk and protective factors.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002574.
    PubMed     Abstract available


  314. JOHNSON LM, Green HD Jr, Koch B, Stockman JK, et al
    Role of social networks and social norms in future PrEP use in a racially-diverse sample of at-risk women and members of their social networks.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002571.
    PubMed     Abstract available


  315. BERES LK, Schwartz S, Simbeza S, McGready J, et al
    Patterns and Predictors of Incident Return to HIV Care Among Traced, Disengaged Patients in Zambia: Analysis of a prospective cohort.
    J Acquir Immune Defic Syndr. 2020 Nov 4. doi: 10.1097/QAI.0000000000002554.
    PubMed     Abstract available


  316. BULTERYS MA, Sharma M, Mugwanya K, Stein G, et al
    Correlates of HIV status non-disclosure by pregnant women living with HIV to their male partners in Uganda: a cross-sectional study.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002566.
    PubMed     Abstract available


  317. PIZZIRUSSO M, Carrion-Park C, Clark US, Gonzalez J, et al
    Physical and mental health screening in a New York City HIV cohort during the COVID-19 pandemic: A preliminary report.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002564.
    PubMed     Abstract available


  318. MAYER ME, White E, Montano MA, Lama JR, et al
    Sexual Behavior among Men Who Have Sex with Men: the Need for More Targeted Outreach to Men Who Also Have Sex with Cisgender Women.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002568.
    PubMed     Abstract available


  319. MIMIAGA MJ, Hughto JMW, Klasko-Foster L, Jin H, et al
    Substance use, mental health problems, and physical and sexual violence additively increase HIV risk between male sex workers and their male clients in Northeastern United States.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002563.
    PubMed     Abstract available


  320. SUMMERS NA, Lahiri CD, Angert CD, Aldredge A, et al
    Metabolic Changes Associated With the Use of Integrase Strand Transfer Inhibitors Among Virally Controlled Women.
    J Acquir Immune Defic Syndr. 2020;85:355-362.
    PubMed     Abstract available


  321. BEBELL LM, Siedner MJ, Ngonzi J, Le MH, et al
    Brief Report: Chronic Placental Inflammation Among Women Living With HIV in Uganda.
    J Acquir Immune Defic Syndr. 2020;85:320-324.
    PubMed     Abstract available


    October 2020
  322. ZHAO H, Li J, Li S, Wang Y, et al
    Comparative analysis of presentation and outcome after liver resection of patients with hepatocellular carcinoma with and without HIV.
    J Acquir Immune Defic Syndr. 2020 Oct 30. doi: 10.1097/QAI.0000000000002561.
    PubMed     Abstract available


  323. CHAHINE A, Koru-Sengul T, Feaster DJ, Dilworth SE, et al
    Blue Monday: Co-Occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis.
    J Acquir Immune Defic Syndr. 2020 Oct 30. doi: 10.1097/QAI.0000000000002560.
    PubMed     Abstract available


  324. KUNIHOLM MH, Bramah-Lawani M, Fitzpatrick M, Nouraie M, et al
    Association of monocyte migration marker CD11b with pulmonary function in people living with HIV.
    J Acquir Immune Defic Syndr. 2020 Oct 28. doi: 10.1097/QAI.0000000000002544.
    PubMed     Abstract available


  325. ROTH AM, Tran NK, Felsher MA, Gadegbeku AB, et al
    Integrating HIV pre-exposure prophylaxis with community-based syringe services for women who inject drugs: Results from the Project SHE demonstration study.
    J Acquir Immune Defic Syndr. 2020 Oct 28. doi: 10.1097/QAI.0000000000002558.
    PubMed     Abstract available


  326. RUDERMAN SA, Crane HM, Nance RM, Whitney BM, et al
    Weight gain following antiretroviral therapy (ART) initiation in ART-naive people living with HIV in the current treatment era.
    J Acquir Immune Defic Syndr. 2020 Oct 28. doi: 10.1097/QAI.0000000000002556.
    PubMed     Abstract available


  327. SCHNEIDER JA, Young L, Ramachandran A, Michaels S, et al
    A Pragmatic Randomized Controlled Trial to Increase Pre-Exposure Prophylaxis Uptake for HIV prevention: 55-week results from PrEPChicago.
    J Acquir Immune Defic Syndr. 2020 Oct 23. doi: 10.1097/QAI.0000000000002518.
    PubMed     Abstract available


  328. EHRENKRANZ P, Grimsrud A, Holmes CB, Preko P, et al
    Expanding the vision for differentiated service delivery: a call for more inclusive and truly patient-centered care for people living with HIV.
    J Acquir Immune Defic Syndr. 2020 Oct 23. doi: 10.1097/QAI.0000000000002549.
    PubMed     Abstract available


  329. DAVIS SM, Habel MA, Pretorius C, Yu T, et al
    Modeling the Impact of Voluntary Medical Male Circumcision (VMMC) on Cervical Cancer in Uganda.
    J Acquir Immune Defic Syndr. 2020 Oct 23. doi: 10.1097/QAI.0000000000002552.
    PubMed     Abstract available


  330. TEIXEIRA DA SILVA D, Bouris A, Ramachandran A, Blocker O, et al
    Embedding a Linkage to Pre-Exposure Prophylaxis (PrEP) Care Intervention in Social Network Strategy and Partner Notification Services: Results from a Pilot Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002548.
    PubMed     Abstract available


  331. GOYAL R, Hu C, Klein PW, Hotchkiss J, et al
    DEVELOPMENT OF A MATHEMATICAL MODEL TO ESTIMATE THE COST-EFFECTIVENESS OF THE RYAN WHITE HIV/AIDS PROGRAM.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002546.
    PubMed     Abstract available


  332. SRINIVASAN K, Heylen E, Raj T, Nyblade L, et al
    Reduction in stigma drivers partially mediates the effect of a stigma reduction intervention among nursing students in India: The DriSti cluster randomized controlled trial.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002543.
    PubMed     Abstract available


  333. HOOVER KW, Khalil GM, Cadwell BL, Rose CE, et al
    Benchmarks for HIV Testing: What is Needed to Achieve Universal Testing Coverage at U.S. Ambulatory Healthcare Facilities.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002553.
    PubMed     Abstract available


  334. GANESH P, Heller T, Chione B, Gumulira J, et al
    NEAR POINT OF CARE HIV VIRAL LOAD: TARGETED TESTING AT LARGE FACILITIES.
    J Acquir Immune Defic Syndr. 2020 Oct 21. doi: 10.1097/QAI.0000000000002555.
    PubMed     Abstract available


  335. GHARE SS, Chilton PM, Rao AV, Joshi-Barve S, et al
    Epigenetic mechanisms underlying HIV-Infection induced susceptibility of CD4+ T cells to enhanced activation-induced FasL expression and cell death.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002526.
    PubMed     Abstract available


  336. BRAUNSTEIN SL, Robbins RS, Ramaswamy C, Daskalakis D, et al
    DRUG OVERDOSE DEATHS AMONG PEOPLE WITH HIV IN NEW YORK CITY, 2007-2017.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002545.
    PubMed     Abstract available


  337. PHILLIPS TR, Fairley CK, Bradshaw FAChSHM CS, Hocking JS, et al
    Group sex among men who have sex with men in the era of PrEP: A cross-sectional study.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002550.
    PubMed     Abstract available


  338. TRUONG HM, Mehrotra ML, Grant RM
    Seroadaptive Behaviors Varied among Geographically-Diverse iPrEx Participants.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002551.
    PubMed     Abstract available


  339. GOYAL R, Luca D, Klein P, Morris E, et al
    Cost-Effectiveness of the Health Resources and Services Administration's Ryan White HIV/AIDS Program.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002547.
    PubMed     Abstract available


  340. GEIDELBERG L, Mitchell KM, Alary M, Mboup A, et al
    A mathematical model impact analysis of a real-life pre-exposure prophylaxis and treatment-as-prevention study among female sex workers in Cotonou, Benin.
    J Acquir Immune Defic Syndr. 2020 Oct 16. doi: 10.1097/QAI.0000000000002535.
    PubMed     Abstract available


  341. MODY A, Sikombe K, Beres LK, Simbeza S, et al
    Profiles of HIV Care Disruptions Among Adult Patients Lost to Follow-up in Zambia: A Latent Class Analysis.
    J Acquir Immune Defic Syndr. 2020 Oct 16. doi: 10.1097/QAI.0000000000002530.
    PubMed     Abstract available


  342. VERHEIJ E, Wit FW, Verboeket SO, Schim van der Loeff MF, et al
    Frequency, risk factors and mediators of frailty transitions during long-term follow-up among people with HIV and HIV-negative AGEhIV Cohort participants.
    J Acquir Immune Defic Syndr. 2020 Oct 16. doi: 10.1097/QAI.0000000000002532.
    PubMed     Abstract available


  343. HU R, Yan H, Liu M, Tang L, et al
    Virologic and immunologic outcomes for HIV patients with coronavirus disease 2019.
    J Acquir Immune Defic Syndr. 2020 Oct 15. doi: 10.1097/QAI.0000000000002540.
    PubMed     Abstract available


  344. WOZNICA DM, Fernando NB, Bonomo EJ, Owczarzak J, et al
    Interventions to improve HIV care continuum outcomes among individuals released from prison or jail: Systematic literature review.
    J Acquir Immune Defic Syndr. 2020 Oct 15. doi: 10.1097/QAI.0000000000002523.
    PubMed     Abstract available


  345. AMELE S, Peters L, Rodger A, Lundgren J, et al
    Effectiveness and safety of IFN-free DAA HCV therapy in HIV/HCV co-infected persons: Results from a pan-European study.
    J Acquir Immune Defic Syndr. 2020 Oct 15. doi: 10.1097/QAI.0000000000002541.
    PubMed     Abstract available


  346. AFFI R, Gabillard D, Dunyach-Remy C, Ntakpe JB, et al
    0.1. Association of plasma sVCAM-1 and sCD14 with mortality in HIV-1 infected West African adults with high CD4 counts.
    J Acquir Immune Defic Syndr. 2020 Oct 14. doi: 10.1097/QAI.0000000000002533.
    PubMed     Abstract available


  347. MCLAUGHLIN TA, Nizam A, Hayara FO, Ouma GS, et al
    Schistosoma mansoni infection is associated with a higher probability of tuberculosis disease in HIV-infected adults in Kenya.
    J Acquir Immune Defic Syndr. 2020 Oct 14. doi: 10.1097/QAI.0000000000002536.
    PubMed     Abstract available


  348. AGUILERA-ALONSO D, Sainz T, Jimenez DE Ory S, Bernardino I, et al
    Clinical, Immunological and Virological Outcomes among youths with perinatal HIV after Transition to Adult Units in Spain from 1997 to 2016.
    J Acquir Immune Defic Syndr. 2020 Oct 14. doi: 10.1097/QAI.0000000000002539.
    PubMed     Abstract available


  349. CALZA L, Bon I, Borderi M, Colangeli V, et al
    COVID-19 OUTCOMES IN PATIENTS WITH UNCONTROLLED HIV-1 INFECTION.
    J Acquir Immune Defic Syndr. 2020 Oct 13. doi: 10.1097/QAI.0000000000002537.
    PubMed    


  350. ECKARD AR, Hughes HY, Hagood NL, O'Riordan MA, et al
    Fecal Calprotectin is Elevated in HIV and Related to Systemic Inflammation.
    J Acquir Immune Defic Syndr. 2020 Oct 13. doi: 10.1097/QAI.0000000000002538.
    PubMed     Abstract available


  351. SACHDEV D, Mara E, Hsu L, Scheer S, et al
    COVID-19 Susceptibility and Outcomes among People Living with HIV in San Francisco.
    J Acquir Immune Defic Syndr. 2020 Oct 8. doi: 10.1097/QAI.0000000000002531.
    PubMed     Abstract available


  352. SHARMA M, Kariithi E, Kemunto E, Otieno G, et al
    High acceptability of assisted partner notification services among HIV-positive females in Kenya: Results from an ongoing implementation study.
    J Acquir Immune Defic Syndr. 2020 Oct 8. doi: 10.1097/QAI.0000000000002527.
    PubMed     Abstract available


  353. PETERS M, Margevicius S, Kityo C, Mirembe G, et al
    The Association of Kidney Disease with Abnormal Cardiac Structure and Function among Ugandans with HIV Infection.
    J Acquir Immune Defic Syndr. 2020 Oct 8. doi: 10.1097/QAI.0000000000002529.
    PubMed     Abstract available


  354. ALBAUGH NW, Nonyane BAS, Mmolawa L, Siwelana T, et al
    Proportion and predictors of adult TB contacts accepting HIV testing during an active TB case finding intervention in South Africa.
    J Acquir Immune Defic Syndr. 2020 Oct 7. doi: 10.1097/QAI.0000000000002509.
    PubMed     Abstract available


  355. HAMMOUD MA, Grulich A, Holt M, Maher L, et al
    Substantial decline in use of HIV pre-exposure prophylaxis (PrEP) following introduction of COVID-19 physical distancing restrictions in Australia: Results from a prospective observational study of gay and bisexual men.
    J Acquir Immune Defic Syndr. 2020 Oct 7. doi: 10.1097/QAI.0000000000002514.
    PubMed     Abstract available


  356. DE BAETSELIER I, Tsoumanis A, Florence E, Van den Berghe W, et al
    Did pre-exposure prophylaxis roll-out influence the epidemic of rectal lymphogranuloma venereum in Belgium? Results from the national surveillance system.
    J Acquir Immune Defic Syndr. 2020 Oct 6. doi: 10.1097/QAI.0000000000002524.
    PubMed     Abstract available


  357. ONONO M, Odwar T, Wahome S, Helova A, et al
    Behavioral interventions can mitigate adverse pregnancy outcomes among women conceiving on antiretroviral therapy (ART) and those initiated on ART during pregnancy: Findings from the MOTIVATE trial in southwestern Kenya.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002521.
    PubMed     Abstract available


  358. JIN H, Biello K, Garofalo R, Lurie M, et al
    Examining the longitudinal predictive relationship between HIV treatment outcomes and pre-exposure prophylaxis use by serodiscordant male couples.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002522.
    PubMed     Abstract available


  359. FABBIANI M, Borghetti A, Squillace N, Colafigli M, et al
    INTEGRASE INHIBITORS USE AND CMV INFECTION PREDICT IMMUNE RECOVERY IN PEOPLE LIVING WITH HIV STARTING FIRST-LINE THERAPY.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002525.
    PubMed     Abstract available


  360. KAPITO-TEMBO AP, Bauleni A, Wesevich A, Ongubo D, et al
    Growth and neurodevelopment outcomes in HIV, tenofovir and efavirenz exposed breastfed infants in PMTCT Option B+ program in Malawi.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002515.
    PubMed     Abstract available


  361. STRATHDEE SA, Martin NK, Pitpitan EV, Stockman JK, et al
    What the HIV Pandemic Experience can Teach the U.S. about the COVID-19 Response.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002520.
    PubMed     Abstract available


  362. BHARTI AR, McCutchan JA, Umlauf A, Okwuegbuna OK, et al
    Asymptomatic Malaria Co-infection of HIV-infected Adults in Nigeria: Prevalence of and Impact on Cognition, Mood and Biomarkers of Systemic Inflammation.
    J Acquir Immune Defic Syndr. 2020 Oct 1. doi: 10.1097/QAI.0000000000002516.
    PubMed     Abstract available


    September 2020
  363. HICKEY MD, Ayieko J, Kwarisiima D, Opel FJ, et al
    Improved Viral Suppression with Streamlined Care in the SEARCH Study.
    J Acquir Immune Defic Syndr. 2020 Sep 24. doi: 10.1097/QAI.0000000000002508.
    PubMed     Abstract available


  364. HARGREAVES JR, Pliakas T, Hoddinott G, Mainga T, et al
    HIV stigma and viral suppression among people living with HIV in the context of universal test and treat: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa.
    J Acquir Immune Defic Syndr. 2020 Sep 24. doi: 10.1097/QAI.0000000000002504.
    PubMed     Abstract available


  365. WANGA V, Mackelprang RD, Thomas KK, Donnell D, et al
    Bacterial vaginosis and risk of HIV infection in the context of CD101 gene variation.
    J Acquir Immune Defic Syndr. 2020 Sep 18. doi: 10.1097/QAI.0000000000002505.
    PubMed     Abstract available


  366. WU L, Schumacher C, Chandran A, Fields E, et al
    Patterns of PrEP Retention among HIV Pre-Exposure Prophylaxis Users in Baltimore City, Maryland.
    J Acquir Immune Defic Syndr. 2020 Sep 15. doi: 10.1097/QAI.0000000000002506.
    PubMed     Abstract available


  367. THIVALAPILL N, Jasumback CL, Perry SH, Dlamini L, et al
    Predicting Sexually Transmitted Infections Among HIV+ Adolescents and Young Adults: A Novel Risk Score to Augment Syndromic Management in Eswatini.
    J Acquir Immune Defic Syndr. 2020 Sep 15. doi: 10.1097/QAI.0000000000002512.
    PubMed     Abstract available


  368. AHRENSTORF G, Jablonka A, Ernst D, Bange FC, et al
    Improved prognosis of infection with M. genavense in immune compromized HIV patients after introduction of combined antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Sep 15. doi: 10.1097/QAI.0000000000002513.
    PubMed    


  369. VITELLI M, Mazelle H, Joncour AL, Amelot A, et al
    A Diagnosis Can Hide Another: The Value of Brain Biopsy in Neurological Lesion of HIV Patients.
    J Acquir Immune Defic Syndr. 2020 Sep 14. doi: 10.1097/QAI.0000000000002511.
    PubMed    


    August 2020
  370. WANG L, Tan DHS, Mishra S
    Evidence of Nonrandom Mixing by Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men Partnerships in Melbourne, 2016 to 2018.
    J Acquir Immune Defic Syndr. 2020;84:e22-e23.
    PubMed    


    July 2020
  371. GAO G, Wang A, Wang S, Qian F, et al
    A retrospective evaluation on the efficacy of Lopinavir/ritonavir and chloroquine to treat non-severe COVID-19 patients.
    J Acquir Immune Defic Syndr. 2020 Jul 22. doi: 10.1097/QAI.0000000000002452.
    PubMed     Abstract available


  372. YAGER J, Castillo-Mancilla J, Ibrahim ME, Brooks KM, et al
    Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study.
    J Acquir Immune Defic Syndr. 2020;84:323-330.
    PubMed     Abstract available


  373. BOFFA JM, Fisher DA, Mayan MJ, Sauve RS, et al
    Effectiveness of Isoniazid Preventive Therapy to Reduce Tuberculosis Incidence in the Context of Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2020;84:e14-e17.
    PubMed    


  374. KASPER P, Phiri S, Chaweza T, Tweya H, et al
    Ambulatory Blood Pressure Monitoring in PLHIV in Malawi: Preliminary Findings.
    J Acquir Immune Defic Syndr. 2020;84:e11-e14.
    PubMed    


    March 2020
  375. SPINELLI MA, Rodrigues WC, Wang G, Vincent M, et al
    HIGH ACCURACY OF A REAL-TIME URINE ANTIBODY-BASED TENOFOVIR POINT-OF-CARE TEST COMPARED TO LABORATORY-BASED ELISA IN DIVERSE POPULATIONS.
    J Acquir Immune Defic Syndr. 2020 Mar 10. doi: 10.1097/QAI.0000000000002322.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: